Source - LSE Regulatory
RNS Number : 9590X
Galantas Gold Corporation
02 May 2023
 

GALANTAS GOLD CORPORATION

TSXV & AIM: Symbol GAL

 

 

GALANTAS REPORT ANNUAL FINANCIAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2022

 

May 2, 2023:  Galantas Gold Corporation (the 'Company') is pleased to announce its audited annual financial results for the year ended December 31, 2022.

 

A copy of the Financial Statements and Management Discussion and Analysis will be sent to shareholders in due course and are available on the Company's website at www.galantas.com/investors.  

 

The Annual and Special Meeting of the Company is to be held at 11:00 a.m. (Toronto time) on 27th June 2023 at The Canadian Venture Building, 82 Richmond Street East, Toronto, Ontario, M5C1P1, Canada.

 

 

Financial Highlights

 

Highlights of the 2022 audited annual results, which are expressed in Canadian Dollars, are summarized below:

 

All figures denominated in Canadian Dollars (CDN$)

 

Year Ended

December 31

 

      2022                     2021

Revenue

$      0

       $      0

Cost and expenses of operations

$    (284,262)

$      (255,901)

Loss before the undernoted

$    (284,262)

$      (255,901)

Depreciation

$     (624,620)

$      (547,991)

General administrative expenses 

$    (5,401,289)

$    (4,332,865)

Foreign exchange (loss)

$       (195,308)

    $     (154,798)

Impairment of Exploration and Evaluation Assets

$       0

$       0

(Loss) / Gain on disposal of property, plant and equipment

$       (2,910)

$       7,124

Impairment

$ (10,124,920)

$       0

Net Loss for the year

$  (16,633,939)

$    (5,284,431)

Working Capital Deficit

$ (11,027,964)

$   (1,095,882)

Cash loss from operating activities before changes in non-cash working capital

$ (2,254,291)

$  (1,678,797)

Cash at December 31, 2022

$ 1,038,643

$     1,069,751

 

Sales revenue for year ended December 31, 2022 amounted to $ Nil as per the year ended December 31, 2021. Provisional concentrate sales totalled US$ 608,000 for 2022 compared to US $ 1,114,000 for the year 2021. However, until the mine commences commercial production, the net proceeds from concentrate sales are being offset against development assets.

 

The Net Loss for the year ended December 31, 2022 amounted to $ 16,633,939 (2021: $5,284,431) and the cash outflow from operating activities before changes in non-cash working capital for the year ended December 31, 2022 amounted to $2,254,291 (2021: $1,678,797). 

 

The Company had a cash balance of $ 1,038,643 at December 31, 2022 compared to $ 1,069,751 at December 31, 2021. The working capital deficit at December 31, 2022 amounted to $ 11,027,964 compared to a working capital deficit of $1,095,882 at December 31, 2021. Current liabilities include financing facilities and loans. Negotiations with current finance providers to extend short-term loans have commenced, are progressing positively and the maturity dates for these loans are expected to be extended beyond December 31, 2023

 

The detailed results and Management Discussion and Analysis (MD&A) are available on www.sedar.com and www.galantas.com and the highlights in this release should be read in conjunction with the detailed results and MD&A. The MD&A provides an analysis of comparisons with previous periods, trends affecting the business and risk factors.

 

Click on, or paste the following link into your web browser, to view the associated PDF document.

http://www.rns-pdf.londonstockexchange.com/rns/9590X_1-2023-4-28.pdf


 

Qualified Person

The financial components of this disclosure has been reviewed by Alan Buckley (Chief Financial Officer) and the production and permitting components by Brendan Morris (CEO), and the exploration and geological components by Dr. Sarah Coulter, all qualified persons under the meaning of NI. 43-101. The information is based upon local production and financial data prepared under their supervision.

 

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS: This press release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995 and applicable Canadian securities laws, including revenues and cost estimates, for the Omagh Gold project. Forward-looking statements are based on estimates and assumptions made by Galantas in light of its experience and perception of historical trends, current conditions and expected future developments, as well as other factors that Galantas believes are appropriate in the circumstances. Many factors could cause Galantas' actual results,  the performance or achievements to differ materially from those expressed or implied by the forward looking statements or strategy, including: gold price volatility; discrepancies between actual and estimated production,  actual and estimated  metallurgical recoveries and throughputs; mining operational risk, geological uncertainties; regulatory restrictions, including environmental regulatory restrictions and liability; risks of sovereign involvement; speculative nature of gold exploration; dilution; competition; loss of or availability of key employees; additional funding requirements; uncertainties regarding planning and other permitting issues; and defective title to mineral claims or property. These factors and others that could affect Galantas's forward-looking statements are discussed in greater detail in the section entitled "Risk Factors" in Galantas' Management Discussion & Analysis of the financial statements of Galantas and elsewhere in documents filed from time to time with the Canadian provincial securities regulators and other regulatory authorities. These factors should be considered carefully, and persons reviewing this press release should not place undue reliance on forward-looking statements. Galantas has no intention and undertakes no obligation to update or revise any forward-looking statements in this press release, except as required by law.

 

 

Information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

Enquiries

Galantas Gold Corporation
Mario Stifano CEO
Email:
info@galantas.com
Website:
www.galantas.com
Telephone: +44 (0) 2882 241100

 

Grant Thornton UK LLP (Nomad)                 

Philip Secrett, Harrison Clarke, George Grainger, Samuel LittlerTelephone: +44(0)20 7383 5100                       

 

S.P Angel Corporate Finance (AIM Broker)

David Hignell, Charlie Bouverat (Corporate Finance)

Grant Barker (Sales and Broking)

Telephone: +44(0)20 3470 0470



 

 

 

 

 

 

 

 

 

 

 

GALANTAS GOLD CORPORATION

Consolidated Financial Statements

(Expressed in Canadian Dollars)

 

Years Ended December 31, 2022 and 2021

 

 

 

 

 

 

 

 

 

 

 


 

 

INDEPENDENT AUDITOR'S REPORT

 

 

To the Shareholders of

Galantas Gold Corporation

Report on the Audit of the Consolidated Financial Statements Opinion

We have audited the consolidated financial statements of Galantas Gold Corporation (the Company), which

comprise the consolidated statements of financial position as at December 31, 2022 and 2021, and the consolidated statements of loss, consolidated statements of comprehensive loss, consolidated statements of cash flows and consolidated statements of changes in equity for the years then ended, and notes to the consolidated financial statements, including a summary of significant accounting policies.

 

In our opinion, the accompanying consolidated financial statements present fairly, in all material respects, the financial position of the Company as at December 31, 2022 and 2021 and its financial performance and its cash flows for the years then ended, in accordance with International Financial Reporting Standards.

 

Basis for Opinion

We conducted our audit in accordance with Canadian generally accepted auditing standards. Our responsibilities under those standards are further described in the Auditor's Responsibilities for the Audit of the Consolidated Financial Statements section of our report. We are independent of the Company in accordance with the ethical requirements that are relevant to our audit of the consolidated financial statements in Canada, and we have fulfilled our other ethical responsibilities in accordance with those requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

 

Material Uncertainty Relating to Going Concern

We draw your attention to Note 1 in the consolidated financial statements, which indicates that the Company incurred a comprehensive loss of $17,797,425 during the year ended December 31, 2022. As stated in Note 1, these events or conditions, along with other matters as set forth in Note 1, indicate that a material uncertainty exists that may cast significant doubt on the Company's ability to continue as a going concern. Our opinion is not modified in respect of this matter.

 

Information Other than the Consolidated financial statements and Auditor's Report Thereon Management is responsible for the other information. The other information comprises the annual management's discussion and analysis, but does not include the consolidated financial statements and our auditor's report thereon.

 

Our opinion on the consolidated financial statements does not cover the other information and we do not express any form of assurance conclusion thereon.

 

In connection with our audit of the consolidated financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the consolidated financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated.

 

If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.


 

Responsibilities of Management and Those Charged with Governance for the Consolidated Financial Statements

Management is responsible for the preparation and fair presentation of the consolidated financial statements in accordance with International Financial Reporting Standards, and for such internal control as management determines is necessary to enable the preparation of consolidated financial statements that are free from material misstatement, whether due to fraud or error.

 

In preparing the consolidated financial statements, management is responsible for assessing the Company's ability to continue as a going concern, disclosing, as applicable, matters relating to going concern and using the going concern basis of accounting unless management either intends to liquidate the Company or to cease operations, or has no realistic alternative but to do so.

 

Those charged with governance are responsible for overseeing the Company's financial reporting process.

 

Auditor's Responsibilities for the Audit of the Consolidated Financial Statements

Our objectives are to obtain reasonable assurance about whether the consolidated financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with Canadian generally accepted auditing standards will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these consolidated financial statements. As part of an audit in accordance with Canadian generally accepted auditing standards, we exercise professional judgment and maintain professional skepticism throughout the audit. We also:

 

·      Identify and assess the risks of material misstatement of the consolidated financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.

 

·      Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control.

 

·      Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by management.

 

·      Conclude on the appropriateness of management's use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Company's ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor's report to the related disclosures in the consolidated financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor's report. However, future events or conditions may cause the Company to cease to continue as a going concern.

 

·      Evaluate the overall presentation, structure and content of the financial statements, including the disclosures, and whether the consolidated financial statements represent the underlying transactions and events in a manner that achieves fair presentation.


 

 

 

·      Obtain sufficient appropriate audit evidence regarding the financial information of the entities or business activities within the Company to express an opinion on the consolidated financial statements. We are responsible for the direction, supervision and performance of the group audit. We remain solely responsible for our audit opinion.

 

 

We also provide those charged with governance with a statement that we have complied with relevant ethical requirements regarding independence, and to communicate with them all relationships and other matters that may reasonably be thought to bear on our independence, and where applicable, related safeguards.

 

The engagement partner on the audit resulting in this independent auditor's report is Pat Kenney.

 

 

 

Chartered Professional Accountants Licensed Public Accountants

 

Mississauga, Ontario

April 28, 2023


 

Galantas Gold Corporation

Consolidated Statements of Financial Position

(Expressed in Canadian Dollars)

 

As at December 31,                                                                                                   2022                        2021

 

ASSETS

 

Current assets

     Cash and cash equivalents                                                                     $       1,038,643                  $ 1,069,751  

     Accounts receivable and prepaid expenses (note 8)                                                 1,810,993           1,279,935  

     Inventories (note 9)                                                                                                      83,242                 108,788     

 

Total current assets                                                                                                   2,932,878                 2,458,474  

 

Non‑current assets                                                                       

     Property, plant and equipment (note 10)                                                                24,255,849               25,688,836

     Long‑term deposit (note 12)                                                                                       489,660                  513,960     

     Exploration and evaluation assets (note 11)                                                             2,665,313                1,574,183  

 

Total non‑current assets                                                                                          27,410,822                27,776,979

 

Total assets                                                                                                      $      30,343,700             $ 30,235,453

 

 

EQUITY AND LIABILITIES

 

Current liabilities

     Accounts payable and other liabilities (notes 13 and 22)                                  $       4,052,041          $ 3,013,999  

     Current portion of financing facilities (note 14)                                                         4,836,267                            -   

     Due to related parties (note 20)                                                                               5,072,534                 124,317    

     Leases (note 15)                                                                                                      -                              416,040

 

Total current liabilities                                                                                             13,960,842                3,554,356  

 

Non‑current liabilities

     Non‑current portion of financing facilities (note 14)                                                    -                           4,247,488

     Due to related parties (note 20)                                                                                 -                           2,444,376

     Decommissioning liability (note 12)                                                                            582,441                    600,525

     Other liability (note 20)                                                                                            1,085,426                    -          

 

Total non‑current liabilities                                                                                        1,667,867                 7,292,389

 

Total liabilities                                                                                                         15,628,709               10,846,745

 

 

Equity

    Share capital (note 16(a)(b))                                                                          69,664,056                     57,783,570

    Reserves                                                                                                        15,515,105                     15,435,369

    Deficit                                                                                                            (70,464,170)                   (53,830,231)          

 

Total equity                                                                                                        14,714,991                     19,388,708

 

Total equity and liabilities                                                                                $      30,343,700           $ 30,235,453

 

 

The notes to the consolidated financial statements are an integral part of these statements.

 

Going concern (note 1)

Incorporation and nature of operations (note 2)

Contingency (note 22)

Events after the reporting period (note 23)

 

Approved on behalf of the Board:

"Mario Stifano"      , Director                                                      "Jim Clancy"          , Director


 

Galantas Gold Corporation

Consolidated Statements of Loss

(Expressed in Canadian Dollars)

                                                                                                                                                      

                                                                                                                                                  Year Ended

                                                                                                                                                December 31,

                                                                                                                                             2022              2021

 

Revenues

     Sales of concentrate (note 18)                                                                                  $         -            $        -         

 

Cost and expenses of operations

     Cost of sales                                                                                                                   284,262           255,901      

     Depreciation (note 10)                                                                                                   624,620           547,991      

 

                                                                                                                                            908,882           803,892      

 

 

Loss before general administrative and other expenses                                                (908,882)       (803,892)          

 

 

General administrative expenses

     Management and administration wages (note 20)                                                       647,763           454,594      

     Other operating expenses                                                                                            526,162           200,507      

     Accounting and corporate                                                                                              291,535           155,615      

     Legal and audit                                                                                                             226,185           123,005      

     Stock‑based compensation (note 16(d))                                                                     1,470,418        2,035,878      

     Shareholder communication and investor relations                                                       506,090           419,590      

     Transfer agent                                                                                                                 45,034             20,165      

     Director fees (note 20)                                                                                                  140,000             99,417      

     General office                                                                                                                    57,423             31,026      

     Accretion expenses (notes 12, 14 and 20)                                                                    691,105           382,178      

     Loan interest and bank charges less deposit interest (notes 14 and 20)                      799,574           410,890      

 

                                                                                                                                          5,401,289        4,332,865      

Other expenses

     Foreign exchange loss                                                                                                  195,938           154,798      

     Loss (gain) on disposal of property, plant and equipment                                                 2,910            (7,124)      

     Impairment of property, plant and equipment (note 10)                                                   10,124,920            -         

 

                                                                                                                                        10,323,768           147,674      

 

 

Net loss for the year                                                                                             $ (16,633,939)   $  (5,284,431)      

 

Basic and diluted net loss per share (note 17)                                                      $           (0.19)  $          (0.08)      

 

Weighted average number of common shares outstanding

     ‑ basic and diluted                                                                                                      89,401,620      64,122,021

 

 

The notes to the consolidated financial statements are an integral part of these statements.


 

Galantas Gold Corporation

Consolidated Statements of Comprehensive Loss

(Expressed in Canadian Dollars)

                                                                                        

                                                                                                                                                  Year Ended

                                                                                                                                                December 31,

                                                                                                                                             2022              2021

 

 

Net loss for the year                                                                                                    $ (16,633,939)  $ (5,284,431)      

Other comprehensive loss

Items that will be reclassified subsequently to profit or loss

       Exchange differences on translating foreign operations                                               (1,163,486)       (124,830)      

 

Total comprehensive loss                                                                                           $ (17,797,425)   $ (5,409,261)      

 

 

The notes to the consolidated financial statements are an integral part of these statements.


 

Galantas Gold Corporation

Consolidated Statements of Cash Flows

(Expressed in Canadian Dollars)

                                                                                                                                                          

                                                                                                                                                  Year Ended

                                                                                                                                                 December 31,

                                                                                                                                           2022                   2021

 

Operating activities

Net loss for the year                                                                                                     $ (16,633,939)       $(5,284,431)

Adjustment for:

     Depreciation (note 10)                                                                                                        624,620           547,991     

     Stock‑based compensation (note 16(d))                                                                          1,470,418         2,035,878

     Accrued interest (notes 14 and 20)                                                                                  1,172,976            321,824

     Foreign exchange (gain) loss                                                                                            292,699               91,973 

     Accretion expenses (notes 12, 14 and 20)                                                                          691,105            345,808

     Impairment of property, plant and equipment (note 10)                                                   10,124,920             -         

     Loss (gain) on disposal of property, plant and equipment                                                      2,910              (7,124)      

Non‑cash working capital items:

     Accounts receivable and prepaid expenses                                                                        438,113         (701,573)   

     Inventories                                                                                                                         21,415              (29,200)     

     Accounts payable and other liabilities                                                                              1,216,455            918,974     

     Due to related parties                                                                                                     (327,111)                 37,256       

     Other liability                                                                                                                  1,085,426                       -   

 

Net cash and cash equivalents used in by operating activities                                      180,007         (1,722,624)

 

Investing activities

Net purchase of property, plant and equipment                                                                 (10,414,099)      (4,426,696)

Proceeds from sale of property, plant and equipment                                                              -                        8,562

Exploration and evaluation assets                                                                                      (1,165,561)         (834,193)   

Lease payments (note 15)                                                                                                     (701,782)         (260,743)   

 

Net cash and cash equivalents used in investing activities                                         (12,281,442)     (5,513,070)

 

Financing activities

Proceeds of private placements (note 16(b)(i))                                                                     5,900,003         7,998,980

Share issue costs                                                                                                               (607,860)          (775,137)

Proceeds from exercise of warrants                                                                                    5,287,147            495,333

Advances from related parties                                                                                             2,062,693             -         

Repayments to related parties                                                                                              (524,255)             -         

Repayment of financing facilities (note 14)                                                                               -                    (23,802)

 

Net cash and cash equivalents provided by financing activities                                12,117,728         7,695,374

 

Net change in cash and cash equivalents                                                                        16,293               459,680     

Effect of exchange rate changes on cash held in foreign currencies                                  (47,401)             (2,023)

Cash and cash equivalents, beginning of year                                                            1,069,751             612,094     

 

Cash and cash equivalents, end of year                                                              $     1,038,643          $ 1,069,751  

 

 

 

Cash                                                                                                                            $     1,038,643    $    1,069,751

Cash equivalents                                                                                                                    -                      -         

 

Cash and cash equivalents                                                                                            $     1,038,643    $    1,069,751

 

 

The notes to the consolidated financial statements are an integral part of these statements.


 

Galantas Gold Corporation

Consolidated Statements of Changes in Equity

(Expressed in Canadian Dollars)

 


    Reserves

 

                                                                                                                                               Equity settled       Foreign

                                                                                                                                                share‑based        currency

                                                                                                      Share             Warrants         payments        translation              

                                                                                                     capital             reserve            reserve             reserve             Deficit                                    Total

 

Balance, December 31, 2020                                         $   52,933,594     $ 340,000      $     8,381,382   $     1,012,739         $  (48,545,800)                   $   14,121,915

     Shares issued in private

          placement (note 16(b)(i))                                                    7,998,980                        -                       -                       -                       -                           7,998,980                                                          

     Warrants issued (note 16(b)(i))                                              (3,258,578)   3,258,578                      -                       -                      -                                              -            

     Warrants issued (note 14(ii))                                                       -                  670,000                      -                       -                       -                     670,000

     Share issue costs                                                                   (783,920)               8,783                  -                       -                      -                         (775,137)                                                          

     Warrant extension (note 20(a)(iii))                                                -                      251,000             -                       -                       -                     251,000    

     Stock‑based compensation (note 16(d))                                     -                       -                   2,035,878                        -                 -                           2,035,878                                                          

     Exercise of warrants                                                             893,494           (398,161)                  -                       -                  -                                      495,333        

     Exchange differences on translating

       foreign operations                                                                   -                       -                       -                    (124,830)             -                   (124,830)    

     Net loss for the year                                                                  -                       -                       -                       -                 (5,284,431)                  (5,284,431)                                                        

 

Balance, December 31, 2021                                                     57,783,570         4,130,200        10,417,260        887,909         (53,830,231)             19,388,708

     Shares issued in private

          placement (note 16(b)(ii))                                                   5,900,003                        -                       -                       -                       -                       5,900,003                                                          

     Shares issued for services arrangement (note 16(b)(ii))             1,000,000                        -                       -                       -                       -           1,000,000                                                                       

     Warrants issued (note 16(b)(ii))                                              (1,644,859)                        1,644,859                      -                       -                      -                    -            

     Warrants issued (note 20(a)(iii))                                                   -                        74,000             -                       -                       -                       74,000    

     Share issue costs (note 16(b)(ii))                                              (752,324)          144,464               -                       -                      -                              (607,860)                    

     Stock‑based compensation (note 16(d))                                     -                       -                1,470,418                        -                       -                     1,470,418                                                          

     Exercise of warrants                                                               7,377,666            (2,090,519)             -                    -                  -                                5,287,147      

     Exchange differences on translating

          foreign operations                                                                -                       -                       -                 (1,163,486)             -                 (1,163,486)    

     Net loss for the year                                                                  -                       -                       -                       -               (16,633,939)                   (16,633,939)                                                      

 

Balance, December 31, 2022                                                $   69,664,056      $ 3,903,004     $   11,887,678   $ (275,577)     $     (70,464,170)              $   14,714,991

 

 

The notes to the consolidated financial statements are an integral part of these statements.




1.       Going Concern

 

These consolidated financial statements have been prepared on a going concern basis which contemplates that Galantas Gold Corporation (the "Company") will be able to realize assets and discharge liabilities in the normal course of business. In assessing whether the going concern assumption is appropriate, management takes into account all available information about the future, which is at least, but is not limited to, twelve months from the end of the reporting period. Management is aware, in making its assessment, of uncertainties related to events or conditions that may cast doubt on the Company's ability to continue as a going concern. The Company's future viability depends on the consolidated results of the Company's wholly‑owned subsidiary Cavanacaw Corporation ("Cavanacaw"). Cavanacaw has a 100% shareholding in both Flintridge Resources Limited ("Flintridge") who are engaged in the acquisition, exploration and development of gold properties, mainly in Omagh, Northern Ireland and Omagh Minerals Limited ("Omagh") who are engaged in the exploration of gold properties, mainly in the Republic of Ireland. The Omagh mine has an open pit mine, which was in production until 2013 when production was suspended and is reported as property, plant and equipment and as an underground mine which having established technical feasibility and commercial viability in December 2018 has resulted in associated exploration and evaluation assets being reclassified as an intangible development asset and reported as property, plant and equipment.

 

The going concern assumption is dependent upon forecast cash flows being met and further financing currently being negotiated. The management's assumptions in relation to future levels of production, gold prices and mine operating and capital costs are crucial to forecast cash flows being achieved. Should production be significantly delayed, revenues fall short of expectations or operating costs and capital costs increase significantly, there may be insufficient cash flows to sustain day to day operations without seeking further finance.

 

Negotiations with current finance providers to extend short‑term loans have commenced, are progressing positively and the maturity dates for both the G&F Phelps Ltd. ("G&F Phelps") and Ocean Partners UK Ltd. ("Ocean Partners") loans are expected to be extended beyond December 31, 2023 (see notes 14 and 20).

 

During the year ended December 31, 2021, the Company raised gross proceeds of $8M through the issuance of shares to new and current investors to meet the financial requirements of the Company for the foreseeable future. During the year ended December 31, 2022, the Company raised gross proceeds of $11M through the issuance of shares to investors and the exercise of warrants. Based on the financial projections prepared, the directors believe it's appropriate to prepare the consolidated financial statements on the going concern basis.

 

As at December 31, 2022, the Company had a deficit of $70,464,170 (December 31, 2021 ‑ $53,830,231). Comprehensive loss for the year ended December 31, 2022 was $17,797,425 (year ended December 31, 2021 ‑ $5,409,261). These conditions raise material uncertainties which may cast significant doubt as to whether the Company will be able to continue as a going concern. However, management believes that it will continue as a going concern. However, this is subject to a number of factors including market conditions. These consolidated financial statements do not reflect adjustments to the carrying values of assets and liabilities, the reported expenses and financial position classifications used that would be necessary if the going concern assumption was not appropriate. These adjustments could be material.

 

2.       Incorporation and Nature of Operations

 

The Company was formed on September 20, 1996 under the name Montemor Resources Inc. on the amalgamation of 1169479 Ontario Inc. and Consolidated Deer Creek Resources Limited. The name was changed to European Gold Resources Inc. by articles of amendment dated July 25, 1997. On May 5, 2004, the Company changed its name from European Gold Resources Inc. to Galantas Gold Corporation. The Company was incorporated to explore for and develop mineral resource properties, principally in Europe. In 1997, it purchased all of the shares of Omagh which owns a mineral property in Northern Ireland, including a delineated gold deposit. Omagh obtained full planning and environmental consents necessary to bring its property into production.

The Company entered into an agreement on April 17, 2000, approved by shareholders on June 26, 2000, whereby Cavanacaw, a private Ontario corporation, acquired Omagh. Cavanacaw has established an open pit mine to extract the Company's gold deposit near Omagh, Northern Ireland. Cavanacaw also has developed a premium jewellery business founded on the gold produced under the name Galántas Irish Gold Limited ("Galántas"). As at July 1, 2007, the Company's Omagh mine began production and in 2013 production was suspended. On April 1, 2014, Galántas amalgamated its jewelry business with Omagh.

 

On April 8, 2014, Cavanacaw acquired Flintridge. Following a strategic review of its business by the Company during 2014 certain assets owned by Omagh were acquired by Flintridge.

 

The Company's operations include the consolidated results of Cavanacaw, and its wholly‑owned subsidiaries Omagh, Galántas and Flintridge.

 

The Company's common shares are listed on the TSX Venture Exchange ("TSXV") and London Stock Exchange AIM under the symbol GAL. On September 1, 2021, the Company's common shares started trading under the symbol GALKF on the OTCQX in the United States. The primary office is located at The Canadian Venture Building, 82 Richmond Street East, Toronto, Ontario, Canada, M5C 1P1.

 

3.       Basis of Preparation

 

(a)     Statement of compliance

 

The consolidated financial statements have been prepared in accordance with International Financial Reporting Standards ("IFRS") issued by the International Accounting Standards Board ("IASB") and interpretations issued by the IFRS Interpretations Committee ("IFRIC"). The Board of Directors approved the consolidated financial statements on April 27, 2023.

 

(b)      Basis of presentation

 

These consolidated financial statements have been prepared on a historical cost basis with the exception of certain financial instruments, which are measured at fair value. In addition, these consolidated financial statements have been prepared using the accrual basis of accounting except for cash flow information.

 

In the preparation of these consolidated financial statements, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of expenses during the year. Actual results could differ from these estimates. Of particular significance are the estimates and assumptions used in the recognition and measurement of items included in note 3(e).

(c)     Basis of consolidation

 

The consolidated financial statements incorporate the financial statements of the Company and its subsidiaries.

 

The results of subsidiaries acquired or disposed of during the years presented are included in the consolidated statement of loss from the effective date of control and up to the effective date of disposal or loss of control, as appropriate. An investor controls an investee if the investor has the power over the investee, has the exposure, or rights, to variable returns from its involvement with the investee and the ability to use its power over the investee to affect the amount of the investor's returns. All intercompany transactions, balances, income and expenses are eliminated upon consolidation.

 

The following wholly owned companies have been consolidated within the consolidated financial statements:

 

Company                                                   Registered                                        Principal activity

 

Galantas Gold Corporation                           Ontario, Canada                                Parent company

Cavanacaw Corporation (1)                            Ontario, Canada                                 Holding company

Omagh Minerals Limited (2)(3)                         Northern Ireland                                 Operating company

Galántas Irish Gold Limited (2)(4)                    Northern Ireland                                 Dormant company

Flintridge Resources Limited (2)(5)                  United Kingdom                                 Operating company

 

 

(1) 100% owned by Galantas Gold Corporation;

(2) 100% owned by Cavanacaw Corporation;

(3) Referred to as Omagh (as defined herein);

(4) Referred to as Galántas (as defined herein); and

(5) Referred to as Flintridge (as defined herein).

 

(d)     Functional and presentation currency

 

The consolidated financial statements are presented in Canadian Dollars ("CAD"), which is the parent Company's presentation and functional currency.

 

Items included in the financial statements of each of the Company's operating subsidiaries are measured using the currency of the primary economic environment in which the entity operates (the "functional currency"). The functional currency of the operating subsidiaries is the U.K. Pound Sterling ("GBP"). The functional currency of the subsidiary Cavanacaw, the holding company, is the CAD.

 

Assets and liabilities of entities with functional currencies other than CAD are translated at the year‑end closing rate of exchange, and the results of their operations are translated at average rates of exchange for the period unless this average is not a reasonable approximation of the cumulative effect of the rates prevailing on the transaction dates, in which case the results of their operations are translated at the rate prevailing on the dates of the transactions. The resulting translation adjustments are recognized as a separate component of equity.

 

                                                                                                                                           Year Ended

                                                                                                                                         December 31,

                                                                                                                                    2022                 2021

 

Closing rate (GBP to CAD)                                                                                            1.6322              1.7132

Average for the year                                                                                                     1.6080              1.7246

 


 

 

(e)     Use of estimates and judgments

 

The preparation of these consolidated financial statements in conformity with IFRS requires management to make certain estimates, judgments and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and reported amounts of revenues and expenses during the reporting period. Actual outcomes could differ from these estimates. These consolidated financial statements include estimates that, by their nature, are uncertain. The impacts of such estimates are pervasive throughout the consolidated financial statements, and may require accounting adjustments based on future occurrences. Revisions to accounting estimates are applied prospectively. These estimates are based on historical experience, current and future economic conditions and other factors, including expectations of future events that are believed to be reasonable under the circumstances.

 

Critical accounting estimates

 

Significant assumptions about the future that management has made that could result in a material adjustment to the carrying amounts of assets and liabilities, in the event that actual results differ from assumptions made, relate to, but are not limited to, the following:

 

· the recoverability of accounts receivable that are included in the consolidated statements of financial position;

· the recoverability of property, plant and equipment in the consolidated statements of financial position. The Omagh underground mine and the open pit mine are considered as one Cash generating unit ("CGU") and is tested for impairment when potential indicators of impairment are present. The calculations of the recoverable amount of CGU determined using the value‑in‑use method require the use of methods such as the discounted cash flow method, which uses assumptions to estimate future cash flows. Significant assumptions applied in the discounted cash flow calculation include: discount rate, foreign exchange rate, gold sale price, grade of ore mined, mill throughput and mill recovery rate;

· the estimated life of the Omagh underground mine ore body based on the estimated recoverable ounces or pounds mined from proven and probable reserves of the mine development costs which impacts the consolidated statements of financial position and the related depreciation included in the consolidated statements of loss;

· the estimated useful lives and residual value of property, plant and equipment which are included in the consolidated statements of financial position and the related depreciation included in the consolidated statements of loss;

· stock‑based compensation - management is required to make a number of estimates when determining the compensation expense resulting from share‑based transactions, including volatility, which is an estimate based on historical price of the Company's share, the forfeiture rate and expected life of the instruments;

· warrants - management is required to make a number of estimates when determining the fair value of the warrants, including volatility and expected life of the instruments;

· premium on call option agreement ‑ management is required to make a number of estimates when determining the premium on the call option agreement including the gold price in future dates.


 

· decommissioning liabilities has been created based on the estimated settlement amounts. Assumptions, based on the current economic environment, have been made which management believes are a reasonable basis upon which to estimate the future liability. These estimates take into account any material changes to the assumptions that occur when reviewed regularly by management. Estimates are reviewed quarterly and are based on current regulatory requirements and constructive obligations. Significant changes in estimates of contamination, restoration standards and techniques will result in changes to liability on a quarterly basis. Actual decommissioning costs will ultimately depend on actual future settlement amount for the decommissioning costs which will reflect the market condition at the time the decommissioning costs are actually incurred. The final cost of the currently recognized decommissioning provisions may be higher or lower than currently provided for.

 

Critical accounting judgments

 

· functional currency - the functional currency for the parent entity and each of its subsidiaries, is the currency of the primary economic environment in which the entity operates. Determination of functional currency may involve certain judgments to determine the primary economic environment and the parent entity reconsiders the functional currency of its entities if there is a change in events and conditions which determined primary economic environment;

· exploration and evaluation assets ‑ the determination of the demonstration of technical feasibility and commercial viability is subject to a significant degree of judgment and assessment of all relevant factors;

· Income taxes - measurement of income taxes payable and deferred income tax assets and liabilities requires management to make judgments in the interpretation and application of the relevant tax laws. The actual amount of income taxes only becomes final upon filing and acceptance of the tax return by the relevant authorities, which occurs subsequent to the issuance of the consolidated financial statements;

· Going concern assumption - Going concern presentation of the consolidated financial statements which assumes that the Company will continue in operation for the foreseeable future and will be able to realize its assets and discharge its liabilities in the normal course of operations as they come due; and

· Whether there are any indicators that the Company's property, plant and equipment assets and exploration and evaluation assets are impaired. Where an indicator of impairment exists for its non‑current assets, the Company performs an analysis to estimate the recoverable amount, which includes various key estimates and assumptions as discussed above.

 

4.       Significant Accounting Policies

 

(a)      Foreign currency transactions

 

Transactions in foreign currencies are translated to the respective functional currencies of the operations at exchange rates at the dates of transactions. Monetary assets and liabilities denominated in foreign currencies at the reporting date are retranslated to the functional currency at the exchange rate at that date. Non‑monetary assets and liabilities denominated in foreign currencies that are measured at fair value are retranslated to the functional currency at the exchange rate at the date that the fair value was determined. Foreign currency differences arising in retranslation are recognized in the consolidated statements of loss, except for differences arising on the retranslation of available‑for‑sale equity instruments which are recognised in other comprehensive loss. Non‑monetary items that are measured in terms of historical cost in foreign currency are translated using the exchange rate at the date of the transaction.


 

 

(b)      Cash and cash equivalents

 

Cash and cash equivalents comprise cash at banks and on hand, and short‑term deposits with an original maturity of three months or less, which are readily convertible into a known amount of cash.

 

(c)      Financial instruments

 

Under IFRS 9 ‑ Financial Instruments ("IFRS 9"), financial assets are classified and measured based on the business model in which they are held and the characteristics of their contractual cash flows. IFRS 9 contains the primary measurement categories for financial assets: measured at amortized cost, fair value through other comprehensive income ("FVTOCI") and fair value through profit and loss ("FVTPL").

 

Below is a summary showing the classification and measurement bases of our financial instruments.

 

 

Financial instruments                                                                                                  Classification

 

Cash and cash equivalents                                                                                                 FVTPL

Accounts receivable                                                                                                     Amortized cost

Long‑term deposit                                                                                                       Amortized cost

Accounts payable and other liabilities                                                                           Amortized cost

Financing facilities                                                                                                       Amortized cost

Due to related parties                                                                                                   Amortized cost

 

 

Financial assets

 

Financial assets are classified as either financial assets at FVTPL, amortized cost, or FVTOCI. The Company determines the classification of its financial assets at initial recognition.

 

i. Financial assets recorded at FVTPL

 

Financial assets are classified as FVTPL if they do not meet the criteria of amortized cost or FVTOCI. Gains or losses on these items are recognized in profit or loss.

 

The Company's cash and cash equivalents is classified as financial assets measured at FVTPL.

 

ii. Amortized cost

 

Financial assets are classified as measured at amortized cost if both of the following criteria are met and the financial assets are not designated as at FVTPL: 1) the object of the Company's business model for these financial assets is to collect their contractual cash flows; and 2) the asset's contractual cash flows represent "solely payments of principal and interest".

 

The Company's accounts receivable and long‑term deposit are classified as financial assets measured at amortized cost.

 

iii. Financial assets recorded at FVTOCI

 

Financial assets are recorded at FVTOCI when the change in fair value is attributable to changes in the Company's credit risk.


 

Financial liabilities

 

Financial liabilities are classified as either financial liabilities at FVTPL or at amortized cost. The Company determines the classification of its financial liabilities at initial recognition.

 

i. Amortized cost

 

Financial liabilities are classified as measured at amortized cost unless they fall into one of the following categories: financial liabilities at FVTPL, financial liabilities that arise when a transfer of a financial asset does not qualify for derecognition, financial guarantee contracts, commitments to provide a loan at a below‑market interest rate, or contingent consideration recognized by an acquirer in a business combination.

 

The Company's accounts payable and other liabilities, financing facilities, due to related parties and leases do not fall into any of the exemptions and are therefore classified as measured at amortized cost.

 

ii. Financial liabilities recorded FVTPL

 

Financial liabilities are classified as FVTPL if they fall into one of the five exemptions detailed above.

 

Transaction costs

 

Transaction costs associated with financial instruments, carried at FVTPL, are expensed as incurred, while transaction costs associated with all other financial instruments are included in the initial carrying amount of the asset or the liability.

 

Subsequent measurement

 

Instruments classified as FVTPL are measured at fair value with unrealized gains and losses recognized in profit or loss. Instruments classified as amortized cost are measured at amortized cost using the effective interest rate method. Instruments classified as FVTOCI are measured at fair value with unrealized gains and losses recognized in other comprehensive loss.

 

Derecognition

 

The Company derecognizes financial liabilities only when its obligations under the financial liabilities are discharged, cancelled, or expired. The difference between the carrying amount of the financial liability derecognized and the consideration paid and payable, including any non‑cash assets transferred or liabilities assumed, is recognized in profit or loss.


 

Expected credit loss impairment model

 

IFRS 9 introduced a single expected credit loss impairment model, which is based on changes in credit quality since initial application. The adoption of the expected credit loss impairment model had no impact on the Company's consolidated financial statements.

 

The Company assumes that the credit risk on a financial asset has increased significantly if it is more than 30 days past due. The Company considers a financial asset to be in default when the borrower is unlikely to pay its credit obligations to the Company in full or when the financial asset is more than 90 days past due.

 

The carrying amount of a financial asset is written off (either partially or in full) to the extent that there is no realistic prospect of recovery. This is generally the case when the Company determines that the debtor does not have assets or sources of income that could generate sufficient cash flows to repay the amounts subject to the write‑off.

 

(d)     Impairment of non‑financial assets

 

When events or circumstances indicate that the carrying value may not be recoverable, the Company reviews the carrying amounts of its non‑financial assets to determine whether events or changes in circumstances indicate that the carrying value may not be recoverable. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). The estimated recoverable amount is determined on an asset by asset basis, except where such assets do not generate cash flows independent of other assets, in which case the recoverable amount is estimated at the CGU level.

 

The recoverable amount is the higher of fair value less costs of disposal and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre‑tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset.

 

If the recoverable amount of an asset (or CGU) is estimated to be less than its carrying amount, the carrying amount of the asset (or CGU) is reduced to its recoverable amount. An impairment loss is recognized immediately in the consolidated statement of comprehensive loss.

 

If an impairment loss subsequently reverses, the carrying amount of the asset (or CGU) is increased up to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognized for the asset (or CGU) in prior years.


 

 

(e)     Property, plant and equipment

 

Property, plant and equipment are carried at cost, less accumulated depreciation and accumulated impairment losses.

 

The cost of an item of property, plant and equipment consists of the purchase price, any costs directly attributable to bringing the asset to the location and condition necessary for its intended use and an initial estimate of the costs of dismantling and removing the item and restoring the site on which it is located.

 

Depreciation is recognized based on the cost of an item of property, plant and equipment, less its estimated residual value, over its estimated useful life at the following rates:

 

Detail                                                                  Percentage                              Method

 

Buildings                                                              20%                                         Declining balance

Plant and machinery                                              20%                                         Declining balance

Motor vehicles                                                      25%                                         Declining balance

Office equipment                                                  15%                                         Declining balance

Development assets                                                                                            No depreciation

Assets under construction                                                                                    No depreciation

 

 

An asset's residual value, useful life and depreciation method are reviewed, and adjusted if appropriate, on an annual basis.

 

(f)      Borrowing Costs

 

General and specific borrowing costs that are directly attributable to the acquisition, construction or production of a qualifying asset are capitalised during the period of time that is required to complete and prepare the asset for its intended use or sale.

 

Qualifying assets are assets that necessarily take a substantial period of time to get ready for their intended use or sale.

 

Investment income earned on the temporary investment of specific borrowings pending their expenditure on qualifying assets is deducted from the borrowing costs eligible for capitalisation.

 

Other borrowing costs are expensed in the period in which they are incurred.

 

(g)     Exploration and evaluation assets

 

These assets relate to the exploration and evaluation expenditures incurred in respect to resource projects that are in the exploration and evaluation stage.

 

Exploration and evaluation expenditures include costs which are directly attributable to acquisition and evaluation activities, assessing technical feasibility and commercial viability. These expenditures are capitalized using the full cost method until the technical feasibility and commercial viability of extracting the mineral resource of a project are demonstrable. During the exploration period, exploration and evaluation assets are not amortized.


 

Exploration and evaluation assets are allocated to CGU for the purpose of assessing such assets for impairment. At the end of each reporting period, the asset is reviewed for impairment indicators in accordance with IFRS 6.20:

 

(i)       the period for which the entity has the right to explore in the specific area has expired during the period or will expire in the near future, and is not expected to be renewed.

(ii)      substantive expenditure on further exploration for and evaluation of mineral resources in the specific area is neither budgeted nor planned.

(iii)     exploration for and evaluation of mineral resources in the specific area have not led to the discovery of commercially viable quantities of mineral resources and the entity has decided to discontinue such activities in the specific area.

(iv)     sufficient data exist to indicate that, although a development in the specific area is likely to proceed, the carrying amount of the exploration and evaluation asset is unlikely to be recovered in full from successful development or by sale.

 

If such indicators exist, the asset is tested for impairment and the recoverable amount of the asset is estimated. If the recoverable amount of the asset is estimated to be less than its carrying amount, the carrying amount of the asset is reduced to its recoverable amount. An impairment loss is recognized immediately in consolidated statements of loss.

 

Once the technical feasibility and commercial viability of extracting a mineral resource of a project are demonstrable, the relevant exploration and evaluation asset is assessed for impairment, and any impairment loss recognized, prior to the balance being reclassified as a development asset in property, plant and equipment.

 

The determination of the demonstration of technical feasibility and commercial viability is subject to a significant degree of judgment and assessment of all relevant factors. In general, technical feasibility may be demonstrable once a positive feasibility study is completed. When determining the commercial viability of a project, in addition to the receipt of a feasibility study, the Company also considers factors such as the availability of project financing, the existence of markets and/or long term contracts for the product, and the ability of obtaining the relevant operating permits.

 

All subsequent expenditures to ready the property for production are capitalized within development assets, other than those costs related to the construction of property, plant and equipment.

 

Once production has commenced, all costs included in development assets are reclassified to mine development costs.

 

Exploration and evaluation expenditures incurred prior to the Company obtaining mineral rights related to the property being explored are recorded as expense in the period in which they are incurred.


 

(h)     Stripping costs

 

Till stripping costs involving the removal of overburden are capitalized where the underlying ore will be extracted in future periods. The Company defers these till stripping costs and amortizes them on a unit‑of‑production basis as the underlying ore is extracted.

 

(i)      Inventories

 

Inventories are comprised of finished goods, concentrate inventory and work‑in‑process amounts.

 

All inventories are recorded at the lower of production costs on a first‑in, first‑out basis, and net realizable value. Production costs include costs related to mining, crushing, mill processing, as well as depreciation on production assets and certain allocations of mine‑site overhead expenses attributable to the manufacturing process.

 

Net realizable value is the estimated selling price in the ordinary course of business, less the estimated costs of completion and selling expenses.

 

(j)       Revenue recognition

 

Revenue from sales of finished goods is recognized at the time of shipment when significant risks and rewards of ownership are considered to be transferred, the terms are fixed or determinable, collection is probable, the associated costs and possible return of goods can be estimated reliably, and there is no continuing management involvement in the goods, and the amount of revenue can be measured reliably.

 

Revenue from sales of gold concentrate is recognized at the time of shipment when title passes and significant risks and benefits of ownership are considered to be transferred and the amount of revenue to be receivable by the Company is known or could be accurately estimated. The final revenue figure at the end of any given period is subject to adjustment at the date of ultimate settlement as a result of final assay agreement and metal prices changes.

 

(k)      Provisions

 

A provision is recognized when the Company has a present legal or constructive obligation as a result of a past event, it is probable that an outflow of economic benefits will be required to settle the obligation, and the amount of the obligation can be reliably estimated. If the effect is material, provisions are determined by discounting the expected future cash flows at a pre‑tax rate that reflects current market assessments of the time value of money and, where appropriate, the risks specific to the liability.

 

A provision for onerous contracts is recognized when the expected benefits to be derived by the Company from a contract are lower than the unavoidable cost of meeting its obligations under the contract.


 

 

(l)       Share‑based compensation transactions

 

Share‑based compensation transactions

Employees (including directors and senior executives) of the Company receive a portion of their remuneration in the form of share‑based compensation transactions, whereby employees render services as consideration for equity instruments ("equity‑settled transactions").

 

In situations where equity instruments are issued and some or all of the goods or services received by the entity as consideration cannot be specifically identified, such as share‑based payments to employees, they are measured at fair value of the share‑based payment.

 

Share‑based payments to employees of the subsidiaries are recognized as cash settled share‑based compensation transactions.

 

Equity‑settled transactions

The costs of equity‑settled transactions with employees are measured by reference to the fair value at the date on which they are granted.

 

The costs of equity‑settled transactions are recognized, together with a corresponding increase in equity, over the period in which the performance and/or service conditions are fulfilled, ending on the date on which the relevant employees become fully entitled to the award ("the vesting date"). The cumulative expense is recognized for equity‑settled transactions at each reporting date until the vesting date reflects the Company's best estimate of the number of equity instruments that will ultimately vest. The profit or loss charge or credit for a period represents the movement in cumulative expense recognized as at the beginning and end of that period and the corresponding amount is represented in "equity settled share‑based payments reserve".

 

No expense is recognized for awards that do not ultimately vest, except for awards where vesting is conditional upon a market condition, which are treated as vesting irrespective of whether or not the market condition is satisfied provided that all other performance and/or service conditions are satisfied.

 

Where the terms of an equity‑settled award are modified, the minimum expense recognized is the expense as if the terms had not been modified. An additional expense is recognized for any modification which increases the total fair value of the share‑based payment arrangement, or is otherwise beneficial to the employee as measured at the date of modification.

 

The dilutive effect of outstanding options (if any) is reflected as additional dilution in the computation of loss per share.

 

Cash‑settled transactions

The cost of cash‑settled transactions is measured initially at fair value. The liability is re‑measured to fair value at each reporting date up to, and including the settlement date, with changes in fair value recognised in employee benefits expense.

 


 

(m)    Income taxes

 

Income tax on the consolidated statements of loss for the years presented comprises current and deferred tax. Income tax is recognized in the consolidated statements of loss except to the extent that it relates to items recognized directly in equity, in which case it is recognized in equity.

 

Current tax expense is the expected tax payable on the taxable income for the year, using tax rates enacted or substantively enacted at period end, adjusted for amendments to tax payable with regards to previous years.

 

Deferred tax is recognized in respect of taxable temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for taxation purposes. Deferred tax is not recognized for the following temporary differences: the initial recognition of assets or liabilities in a transaction that is not a business combination and that affects neither accounting nor taxable profit or loss, and differences relating to investments in subsidiaries and joint ventures to the extent that it is probable that they will not reverse in the foreseeable future. In addition, deferred tax is not recognized for taxable temporary differences arising on the initial recognition of goodwill. Deferred tax is measured at the tax rates that are expected to be applied to taxable temporary differences when they reverse, based on the laws that have been enacted or substantively enacted by the reporting date. Deferred tax assets and liabilities are offset if there is a legally enforceable right to offset current tax liabilities and assets, and they relate to income taxes levied by the same tax authority on the same taxable entity, but they intend to settle current tax liabilities and assets on a net basis or their tax assets and liabilities will be realized simultaneously.

 

A deferred tax asset is recognized for unused tax losses, tax credits and deductible temporary differences, to the extent that it is probable that future taxable profits will be available against which they can be utilized. Deferred tax assets are reviewed at each reporting date and are reduced to the extent that it is no longer probable that the related tax benefit will be realized.

 

(n)      Decommissioning liability

 

A legal or constructive obligation to incur restoration, rehabilitation and environmental costs may arise when environmental disturbance is caused by the exploration, development or ongoing production of a mineral property interest.  Such costs arising from the decommissioning of plant and other site preparation work, discounted to their net present value, are provided for and capitalized at the start of each project to the carrying amount of the asset, when there is a present obligation, as a result of a past event, it is probable to be settled by a future outflow of resources and a reliable estimate can be made of the obligation. Discount rates using a pretax rate that reflects the risk and the time value of money are used to calculate the net present value. These costs are charged against the consolidated statements of loss over the economic life of the related asset, through amortization using either a unit‑of‑production or the straight‑line method as appropriate. The related liability is adjusted for each period for the unwinding of the discount rate and for changes to the current market‑based discount rate, amount or timing of the underlying cash flows needed to settle the obligation. Costs for restoration of subsequent site damage that is created on an ongoing basis during production are provided for at their net present values and charged against profits and/or inventories as extraction progresses.


 

(o)     Loss per share

 

The Company presents basic and diluted loss per share data for its common shares, calculated by dividing the loss attributable to common shareholders of the Company by the weighted average number of common shares outstanding during the year. Diluted loss per share is computed similarly to basic loss per share except that the weighted average shares outstanding are increased to include additional shares for the assumed exercise of stock options and warrants, if dilutive.  The number of additional shares is calculated by assuming that outstanding stock options and warrants were exercised and that the proceeds from such exercises were used to acquire common stock at the average market price during the years.  Options and warrants are anti‑dilutive and, therefore, have not been taken into account in the per share calculation.

 

(p)      Leases

 

At inception of a contract, the Company assesses whether a contract is, or contains, a lease. Contracts that convey the right to control the use of an identified asset for a period of time in exchange for consideration are accounted for as leases giving rise to right‑of‑use assets.

 

At the commencement date, a right‑of‑use asset is measured at cost, where cost comprises: (a) the amount of the initial measurement of the lease liability; (b) any lease payments made at or before the commencement date, less any lease incentives received; (c) any initial direct costs incurred by the Company; and (d) an estimate of costs to be incurred by the Company in dismantling and removing the underlying asset, restoring the site on which it is located or restoring the underlying asset to the condition required by the terms and conditions of the lease, unless those costs are incurred to produce inventories.

 

The Company subsequently measures a right‑of‑use asset at cost less any accumulated depreciation and any accumulated impairment losses; and adjusted for any re‑measurement of the lease liability. Right‑of‑use assets are depreciated over the shorter of the asset's useful life and the lease term.

 

A lease liability is initially measured at the present value of the unpaid lease payments. Subsequently, the Company measures a lease liability by: (a) increasing the carrying amount to reflect interest on the lease liability; (b) reducing the carrying amount to reflect the lease payments made; and (c) remeasuring the carrying amount to reflect any reassessment or lease modifications, or to reflect revised in‑substance fixed lease payments. Each lease payment is allocated between repayment of the lease principal and interest. Interest on the lease liability in each period during the lease term is allocated to produce a constant periodic rate of interest on the remaining balance of the lease liability.

 

Except where the costs are included in the carrying amount of another asset, the Company recognizes in profit or loss (a) the interest on a lease liability and (b) variable lease payments not included in the measurement of a lease liability in the period in which the event or condition that triggers those payments occurs.

 

The Company elected to not recognize right‑of‑use assets and lease liabilities that have a lease term of 12 months or less and leases of low‑value assets. The lease payments associated with these leases are charged directly to profit on a straight‑line basis over the lease term.

 


5.       Capital Risk Management

 

The Company manages its capital with the following objectives:

 

·            to ensure sufficient financial flexibility to achieve the ongoing business objectives including funding of future growth opportunities, and pursuit of accretive acquisitions; and

·      to maximize shareholder return.

 

The Company monitors its capital structure and makes adjustments according to market conditions in an effort to meet its objectives given the current outlook of the business and industry in general. The Company may manage its capital structure by issuing new shares, repurchasing outstanding shares, adjusting capital spending, or disposing of assets. The capital structure is reviewed by management and the Board of Directors on an ongoing basis.

 

The Company considers its capital to be equity, comprising share capital, reserves and deficit which at December 31, 2022 totaled $14,714,991 (December 31, 2021 ‑ $19,388,708). The Company manages capital through its financial and operational forecasting processes. The Company reviews its working capital and forecasts its future cash flows based on future sales revenues, operating expenditures, and other investing and financing activities. The forecast is updated based on its operating and exploration activities. Selected information is provided to the Board of Directors of the Company. The Company's capital management objectives, policies and processes have remained unchanged during the year ended December 31, 2022. The Company is not subject to any capital requirements imposed by a lending institution or regulatory body.

 

6.       Financial and Property Risk Management

 

Property risk

 

The Company's significant project is the Omagh mine. Unless the Company acquires or develops additional significant projects, the Company will be solely dependent upon the Omagh mine. If no additional projects are acquired by the Company, any adverse development affecting the Omagh mine would have a material effect on the Company's consolidated financial condition and results of operations.

 

Financial risk

 

The Company's activities expose it to a variety of financial risks: credit risk and sales concentration, liquidity risk and market risk (including interest rate risk, foreign currency risk and commodity and equity price risk). Risk management is carried out by the Company's management team with guidance from the Audit Committee under policies approved by the Board of Directors. The Board of Directors also provides regular guidance for overall risk management.

 

(i) Credit risk and sales concentration

 

Credit risk is the risk of loss associated with a counterparty's inability to fulfill its payment obligations. The Company's credit risk is primarily attributable to cash and cash equivalents, accounts receivable and long‑term deposit. Cash and long‑term deposit are held with financial institutions and the United Kingdom Crown, respectively, from which management believes the risk of loss to be minimal. All the revenue from sales are from one customer and the accounts receivable consist mainly of a trade account receivable from one customers, value added tax receivable and sales tax receivable. The Company is exposed to concentration of credit and sales risk with one of its customers. Management believes that the credit risk is minimized due to the financial worthiness of this company. Valued added tax receivable is collectable from the Government of Northern Ireland. Sales tax receivable is collectable from government authorities in Canada.

 


 

(ii) Liquidity risk

 

Liquidity risk is the risk that the Company will not have sufficient cash resources to meet its financial obligations as they come due. The Company's liquidity and operating results may be adversely affected if the Company's access to the capital market is hindered, whether as a result of a downturn in stock market conditions generally or matters specific to the Company. The Company manages liquidity risk by monitoring maturities of financial commitments and maintaining adequate cash reserves and available borrowing facilities to meet these commitments as they come due.  As at December 31, 2022, the Company had working capital deficit of $11,027,964 (December 31, 2021 ‑ working capital deficit of $1,095,882). All of the Company's financial liabilities have contractual maturities of less than 30 days other than certain related party loans which are due on demand and the financing liabilities.

 

(iii) Market risk

 

Market risk is the risk of loss that may arise from changes in market factors such as interest rate risk, foreign exchange rate risk and commodity price risk.

 

(a) Interest rate risk

 

Interest rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate due to changes in market interest rates. The Company has cash balances, significant interest‑bearing debt due to related parties and financing facility. The Company is exposed to interest rate risk on certain related party loans and third party loans which bear interest at variable rates.

 

(b) Foreign currency risk

 

Certain of the Company's assets, liabilities are designated in GBP and expenses are incurred in GBP which is the currency of Northern Ireland and the United Kingdom while the Company's primary revenues are received in the currency of United States and are therefore subject to gains and losses due to fluctuations in these currencies against the functional currency. The loan from third party is designated in US dollars.

 

(c) Commodity price risk

 

The Company is exposed to price risk with respect to commodity prices. Commodity price risk is defined as the potential adverse impact on earnings and economic value due to commodity price movements and volatilities. The Company closely monitors commodity prices, as it relates to gold to determine the appropriate course of action to be taken by the Company.

 


 

Sensitivity analysis

 

Based on management's knowledge and experience of the financial markets, the Company believes the following movements are reasonably possible over a twelve month period:

 

(i) Certain related party loans and a loan facility with a third party are subject to interest rate risk. As at December 31, 2022, if interest rates had decreased/increased by 1% with all other variables held constant, the net loss for the year ended December 31, 2022, would have been approximately $98,000 lower/higher respectively, as a result of lower/higher interest rates from certain related party loans and a loan facility. Similarly, as at December 31, 2022, shareholders' equity would have been approximately $98,000 higher/lower as a result of a 1% decrease/increase in interest rates from certain related party loans and a loan facility.

 

(ii) The Company is exposed to foreign currency risk on fluctuations related to cash and cash equivalents, accounts receivable, long‑term deposit, accounts payable and other liabilities, financing liability, lease liability and due to related parties that are denominated in GBP. As at December 31, 2022, had the GBP weakened/strengthened by 5% against the CAD with all other variables held constant, the Company's consolidated comprehensive loss for the year ended December 31, 2022 would have been approximately $487,000 higher/lower as a result of foreign exchange losses/gains on translation of non‑CAD denominated financial instruments. Similarly, as at December 31, 2022, shareholders' equity would have been approximately $487,000 higher/lower had the GBP weakened/strengthened by 5% against the CAD as a result of foreign exchange losses/gains on translation of non‑CAD denominated financial instruments.

 

(iii) Commodity price risk could adversely affect the Company. In particular, the Company's future profitability and viability of development depends upon the world market price of gold. Gold prices have fluctuated widely in recent years. There is no assurance that, even as commercial quantities of gold may be produced in the future, a profitable market will exist for them. A decline in the market price of gold may also require the Company to reduce production of its mineral resources, which could have a material and adverse effect on the Company's value. Management believes that the impact would be immaterial for the year ended December 31, 2022.

 


7.       Categories of Financial Instruments

 

 

As at December 31,                                                                                                          2022                2021

 

Financial assets:                                 

     FVTPL

          Cash and cash equivalents                                                                               $     1,038,643   $     1,069,751

     Amortized cost

         Accounts receivable                                                                                                  420,653            998,728

          Long‑term deposit                                                                                                     489,660            513,960

 

Financial liabilities:

     Amortized cost

         Accounts payable and other liabilities                                                                      4,052,041          3,013,999

         Financing facilities                                                                                                  4,836,267          4,247,488

         Due to related parties                                                                                             5,072,534       2,568,693       

 

 

As of December 31, 2022 and 2021, the fair value of all the Company's financial instruments approximates the carrying value.

 

8.       Accounts Receivable and Prepaid Expenses

 

As at December 31,                                                                                                   2022                        2021

 

 


Sales tax receivable ‑ Canada                                                                             $            22,971             $ 4,471        

Valued added tax receivable ‑ Northern Ireland                                                                281,308              239,774     

Accounts receivable                                                                                                       116,374                   594,071     

Prepaid expenses                                                                                                      1,390,340                     281,207     

Other debtors                                                                                                               -                              160,412

 

                                                                                                                         $       1,810,993                $ 1,279,935  

 

 

Prepaid expenses includes advances for consumables and for construction of the passing bays in the Omagh mine. Prepaid expenses includes also $1,000,000 pursuant to services agreement as disclosed in note 16(b)(ii).

 

The following is an aged analysis of receivables:

 

As at December 31,                                                                                                   2022                        2021

 


Less than 3 months                                                                                            $          343,381             $ 884,550     

3 to 12 months                                                                                                                51,868                  105,526     

More than 12 months                                                                                                       25,404                      8,652

 

Total accounts receivable                                                                                   $          420,653           $ 998,728     

 

 

9.       Inventories

 

As at December 31,                                                                                                   2022                        2021

 


Concentrate inventories                                                                                      $            83,242         $ 108,788     

 


 

Galantas Gold Corporation

Notes to Consolidated Financial Statements

Years Ended December 31, 2022 and 2021

(Expressed in Canadian Dollars)

 

10.     Property, Plant and Equipment

                                                                         Freehold             Plant                                                                  

                                                                         land and              and                Motor               Office         Development    Assets under

Cost                                                                 buildings      machinery (i)       vehicles         equipment        assets (ii)       construction           Total

 

Balance, December 31, 2020                   $     2,398,171   $     6,951,208           $ 162,571               $        191,422   $ 19,345,676      $                  -                                $ 29,049,048    

Additions                                          -                   1,263,168                        38,975                           27,973          4,898,703                   556,273                                              6,785,092      

Disposals                                             -                       (6,289)                        -                       -                       -                       -                                    (6,289)                  

Cash receipts from concentrate sales                        -                       -                       -                       -                 (1,412,329)             -                  (1,412,329)

Foreign exchange adjustment                        (34,357)            (99,099)                        (2,329)                           (2,742)   (270,376)                              -                                                   (408,903)      

 

Balance, December 31, 2021                     2,363,814          8,108,988                        199,217                        216,653        22,561,674                                      556,273               34,006,619    

Additions                                                                 -                      464,632                        45,599                             9,619   11,008,120                           -                            11,527,970                       

Disposals                                                                -                       -                      (14,531)             -                       -                       -                      (14,531)

Transfer                                                                   -                      529,972                        -                       -                       -                         (529,972)                                                  -                       

Cash receipts from concentrate sales                        -                       -                       -                       -                    (823,475)             -                    (823,475)

Impairment (iii)                                                         -                       -                       -                       -               (10,124,920)             -                (10,124,920)

Foreign exchange adjustment                                (111,761)          (381,794)              (9,419)                 (10,243)        (1,219,359)                                                   (26,301)               (1,758,877)    

 

Balance, December 31, 2022                          $     2,252,053   $     8,721,798             $ 220,866               $        216,029   $ 21,402,040      $                  -                              $ 32,812,786    

 

Accumulated depreciation                                      

 

Balance, December 31, 2020                          $     1,986,461   $     5,648,586          $ 130,107               $ 125,791           $        -             $                  -                                 $ 7,890,945      

Depreciation                                                               6,347            507,876                        19,776                  13,992                       -                      -                                 547,991                       

Disposals                                                                -                       (4,801)                        -                       -                       -                       -                                    (4,801)                  

Foreign exchange adjustment                  (28,499)            (83,963)                        (1,995)                 (1,895)                       -                                -                                              (116,352)      

 

Balance, December 31, 2021                        1,964,309          6,067,698                        147,888               137,888                      -                                -                                8,317,783      

Depreciation                                  4,734            587,131                        20,676                  12,510                       -                                -                                 625,051                       

Disposal                                                                  -                       -                       (3,268)             -                       -                       -                       (3,268)

Foreign exchange adjustment             (92,801)          (276,816)                        (6,681)                 (6,331)                       -                                -                                           (382,629)      

 

Balance, December 31, 2022                          $     1,876,242   $     6,378,013       $ 158,615               $ 144,067           $        -             $                  -                                  $ 8,556,937      

 

Carrying value                                

 

Balance, December 31, 2021               $        399,505   $     2,041,290        $ 51,329                $         78,765   $   22,561,674                      $                         556,273             $ 25,688,836    

 

Balance, December 31, 2022                          $        375,811   $     2,343,785        $ 62,251                $         71,962   $ 21,402,040      $                  -                                               $ 24,255,849    

 

(i) Right‑of‑use assets of $680,520 is included in additions of the plant and machinery for the year ended December 31, 2021. Right‑of‑use assets of $282,041 is included in additions of the plant and machinery for the year ended December 31, 2022.

(ii) Development assets are expenditures for the underground mining operations in Omagh.

 


 

(iii) The Company conducts impairment testing on an annual basis. The cash generating unit for the purpose of impairment testing is the Omagh Mine. The basis on which the recoverable amount is assessed is its value in use. The cash flow forecast employed for the value in use computation is for a five year period discounted at a rate reflective of market conditions.

 

The most critical assumption for the value in use calculation was the granting of planning permission for the development of an underground mine. Planning permission was granted but was the subject of a judicial review which found in favour of the Company in September 2017. The judicial review decision was then appealed by a third party to the Court of Appeal in relation to the positive judicial review judgment. This appeal was completed in February 2018 and later in 2018 the Court of Appeal delivered its judgement in regard to an appeal against the Company's planning consent. The Court determined that the appeal had failed and thus the planning consent is confirmed.

 

As of December 31, 2022, the Company performed its annual impairment tests for development assets. The recoverable amount of the Company's cash generating unit was determined based on their value‑in‑use using Level 3 inputs in a discounted cash flow model. The key assumptions used in the estimates of the recoverable amounts are described as follows:

 

·      Cash flows: Estimated cash flows were projected based on the Company's business plans, which are based on actual operating results from internal sources as well as industry and market trends. The forecasts were extended to a total of 5 years;

·      Discount rate: The post tax discount rates were approximately 15‑16%.

 

As at December 31, 2022, management determined the development assets was impaired by $10,124,920.

 

11.     Exploration and Evaluation Assets

 

                                                                                                                                                            Exploration

                                                                                                                                                                  and

                                                                                                                                                             evaluation

Cost                                                                                                                                                         assets

 


Balance, December 31, 2020                                                                                                               $        750,741

Additions                                                                                                                                                     834,193

Foreign exchange adjustment                                                                                                                       (10,751)

 

Balance, December 31, 2021                                                                                                                      1,574,183

Additions                                                                                                                                                  1,165,561

Foreign exchange adjustment                                                                                                                       (74,431)

 

Balance, December 31, 2022                                                                                                               $     2,665,313

 

 

Carrying value                                                                                                                                             

 


Balance, December 31, 2021                                                                                                               $     1,574,183

 

Balance, December 31, 2022                                                                                                               $     2,665,313

 


12.     Decommissioning Liability

 

The Company's decommissioning liability is a result of mining activities at the Omagh mine in Northern Ireland. The Company estimated its decommissioning liability at December 31, 2022 based on a risk‑free discount rate of 1% (December 31, 2021 ‑ 1%) and an inflation rate of 1.50% (December 31, 2021 ‑ 1.50%). The expected undiscounted future obligations allowing for inflation are GBP 330,000 and based on management's best estimate the decommissioning is expected to occur over the next 5 to 10 years. On December 31, 2022, the estimated fair value of the liability is $582,441 (December 31, 2021 ‑ $600,525). Changes in the provision during the year ended December 31, 2022 are as follows:

 

                                                                                                                                 As at                       As at

                                                                                                                          December 31,          December 31,

                                                                                                                                 2022                        2021

 

Decommissioning liability, beginning of year                                                       $          600,525     $ 598,275     

Accretion                                                                                                                         10,154                  10,892       

Foreign exchange                                                                                                          (28,238)            (8,642)      

 

Decommissioning liability, end of year                                                                $          582,441           $ 600,525     

 

 

As required by the Crown in Northern Ireland, the Company is required to provide a bond for reclamation related to the Omagh mine in the amount of GBP 300,000 (December 31, 2021 ‑ GBP  300,000), of which GBP 300,000 was funded as of December 31, 2022 (GBP 300,000 was funded as of December 31, 2021) and reported as long‑term deposit of $489,660 (December 31, 2021 ‑ $513,960).

 

13.     Accounts Payable and Other Liabilities

 

Accounts payable and other liabilities of the Company are principally comprised of amounts outstanding for purchases relating to exploration costs on exploration and evaluation assets, general operating activities and professional fees activities.

 

As at December 31,                                                                                                   2022                        2021

 

Accounts payable                                                                                              $       2,528,245            $ 1,463,316  

Accrued liabilities                                                                                                        1,523,796             1,550,683  

 

Total accounts payable and other liabilities                                                         $       4,052,041         $ 3,013,999  

 

 

The following is an aged analysis of the accounts payable and other liabilities:

 

As at December 31,                                                                                                   2022                        2021

 

Less than 3 months                                                                                            $       2,939,972             $ 2,246,440  

3 to 12 months                                                                                                              412,168              98,415       

12 to 24 months                                                                                                               61,247                   -          

More than 24 months (see also note 22)                                                                          638,654                    669,144

 

Total accounts payable and other liabilities                                                         $       4,052,041           $ 3,013,999  

 


14.     Financing Facilities

 

Amounts payable on the Company's financial facilities are as follow:

 

As at December 31,                                                                                                   2022                        2021

 


Ocean Partners

Financing facilities, beginning of period (i)                                                          $          -                  $       2,186,272

Repayment of financing facilities (i)                                                                               -                              (23,802)

Accretion (i)                                                                                                                  -                              126,949

Interest (i)                                                                                                                     -                                86,820

Foreign exchange adjustment                                                                                        -                              200,898

Financing facility reallocated to due to related parties (i)                                                 -                         (2,577,137)

Less current portion                                                                                                  (4,836,267)                    -          

 

                                                                                                                                (4,836,267)                                -   

 

G&F Phelps

Financing facility, beginning of period                                                                         4,247,488                     -         

Financing facility reallocated from due to related parties (ii)                                            -                           4,578,039

Less bonus warrants issued (ii)                                                                                      -                            (670,000)

Accretion (ii)                                                                                                                  269,512             151,290     

Interest (ii)                                                                                                                     618,903             164,197     

Repayment                                                                                                                    (24,120)                               -   

Foreign exchange adjustment                                                                                       (275,516)                      23,962

 

                                                                                                                                  4,836,267             4,247,488  

 

 

Financing facilities ‑ non‑current portion                                                          $          -                     $     4,247,488

 

 

(i) In April 2018, the Company signed a concentrate pre‑payment agreement and loan facility for US$1.6 million with a United Kingdom based company (the "Lender"), with a maturity date of December 31, 2020. The interest was set at US$ 12 month LIBOR + 8.75% and payable monthly. No interest shall be charged for 6 months and repayments commenced against deliveries in 2019. There was a US$25,000 arrangement fee.

 

In respect of the loan facility, a fixed and floating security, subordinated to an existing security to G&F Phelps, is being put in place over Flintridge assets. G&F Phelps has a first charge on Flintridge assets in respect of its loan facility and the Lender required an intercreditor agreement between G&F Phelps and the Lender.

 

As consideration for the loan facility, the United Kingdom based company received 1,500,000 bonus warrants of the Company. Each bonus warrant is exercisable into one common share of the Company and is subject to an initial four months plus one day hold period from the date of issuance of the bonus warrants. The bonus warrants had a maximum life of two years (the "Expiry Time"). On April 19, 2018, the 1,500,000 bonus warrants were granted. In the event that the weighted average closing price per common share of the Company is more than $2.00 per share for more than five consecutive trading days, the Company shall be entitled to accelerate the Expiry Time to a date that is 30 days from the date on which the Company announces the accelerated Expiry Time by press release.

 

The fair value of the 1,500,000 bonus warrants was estimated at $786,000 using the Black‑Scholes option pricing model with the following assumptions: expected dividend yield ‑ 0%, expected volatility ‑ 113.55%, risk‑free interest rate ‑ 1.91% and an expected average life of 2 years.


 

 

On July 9, 2020, the Company amended the terms of its loan facility of an increase in the outstanding loan facility. The amount of the loan facility increased by US$200,000 to a total of US$1.8 million. On November 12, 2020, the additional US$200,000 loan facility was drawn down by the Company. The interest rate applicable on the loan facility increased from US$ 12 month LIBOR + 8.75% to US$ 12 month LIBOR + 9.9% and the maturity date was extended from December 31, 2020 to December 31, 2021. Interest could be rolled into the loan facility until December 31, 2021, at the Company's option.

 

As consideration for amending the terms of the loan facility, the Lender received on August 14, 2020, 1,700,000 bonus warrants of Galantas ("Bonus Warrants"). Each Bonus Warrant was exercisable for one common share of Galantas (a "Bonus Share") at an exercise price of $0.33 per Bonus Share. The Bonus Warrants had an expiration date of December 31, 2021 (the "Expiry Date") and the Bonus Shares were subject to an initial four month plus one day hold period from the date of their issuance. In the event that the weighted average closing price per common share of the Company is more than $0.4125 per share for more than five consecutive trading days, the Company shall be entitled to accelerate the Expiry Date to a date that is 30 days from the date on which the Company announces the accelerated Expiry Date by press release.

 

The fair value of the 1,700,000 bonus warrants was estimated at $340,000 using the Black‑Scholes option pricing model with the following assumptions: expected dividend yield ‑ 0%, expected volatility ‑ 165.75%, risk‑free interest rate ‑ 0.27% and an expected average life of 1.38 years.

 

2021 activities

 

On May 14, 2021, the maturity date of the loan facility due on December 31, 2021 was extended to December 31, 2023. Interest may be deferred and added to the balance outstanding until March 31, 2022, at which point interest will be paid monthly.

 

The 1,700,000 Bonus Warrants issued have been extended. The Company recorded the incremental difference of $251,000 as financing costs based on the fair value of these warrants immediately prior to and after the modification. The fair value of the 1,700,000 Bonus Warrants was valued immediately prior to the subsequent extension using the following Black‑Scholes option pricing model with the following assumptions: expected dividend yield ‑ 0%, expected volatility ‑ 123.98% to 144.48%, risk‑free interest rate ‑ 0.32% and an expected average life of 0.63 to 2.63 years.

 

During the year ended December 31, 2021, the Company recorded accretion expense of $126,949 in the consolidated statements of loss in regards with this loan facility.

 

During the year ended December 31, 2021, the Company recorded interest expense of $86,820 in the consolidated statements of loss in regards with this loan facility.

 

During the year ended December 31, 2021, the Company recorded a repayment of $23,802 in regards with this loan facility.

 

As at June 30, 2021, the Lender and the Company have a common director. As a result, the balance due to the Lender was reallocated from financing facilities to due to related parties. Total balance reallocated consisted of $2,577,137. Refer to note 20(a)(iii).

 

(ii) In connection with the closing of the private placement completed on May 14, 2021 (refer to note 16(b)(ii)), Roland Phelps has retired as the Company's President and Chief Executive Officer and as a member of the Board of Directors. As a result, the balance due to G&F Phelps, a company controlled by Roland Phelps was reallocated from due to related parties to financing facilities. The total balance reallocated consisted of $3,163,593 (GBP 1,824,764) amalgamated loans balance and $1,414,446 (GBP 815,854) interest accrued balance. Refer to note 20(a)(i).


 

2022 activities

 

As at December 31, 2022, G&F Phelps had amalgamated loans to the Company of $2,719,042 (GBP 1,665,875) (December 31, 2021 ‑ $2,607,493 ‑ GBP 1,522,802) included with financing facilities bearing interest at 2% above UK base rates, repayable on demand and secured by a mortgage debenture on all the Company's assets. In April 2018, the interest increased to 6.75% + US$ 12 month LIBOR. Interest accrued on G&F Phelps loan is included with financing facilities. As at December 31, 2022, the amount of interest accrued is $1,950,675 (GBP 1,195,120) (December 31, 2021 ‑ $1,639,995 ‑ GBP 957,270). 

 

The maturity date of the G&F Phelps loan has been extended to December 31, 2023. Interest may be deferred and added to the balance outstanding until March 31, 2022, at which point interest will be paid monthly. In consideration for extending the G&F loan and deferring interest, G&F Phelps has received, subject to regulatory approval, 1,700,000 warrants exercisable into one common share at an exercise price of $0.33, with said warrants expiring on December 31, 2023. 

 

The fair value of the 1,700,000 warrants was estimated at $670,000 using the following Black‑Scholes option pricing model with the following assumptions: expected dividend yield ‑ 0%, expected volatility ‑ 123.98% to 144.48%, risk‑free interest rate ‑ 0.32% and an expected average life of 2.63 years.

 

During the year ended December 31, 2022, the Company recorded accretion expense of $269,512 in the consolidated statements of loss in regards with this loan facility (year ended December 31, 2021 ‑ $151,290).

 

During the year ended December 31, 2022, the Company recorded interest expense of $618,903 in the consolidated statements of loss in regards with this loan facility (year ended December 31, 2021 ‑ $164,197).

 

15.     Leases

 

 

Balance, December 31, 2020                                                                                                            $        -         

Addition (i)                                                                                                                                                680,520

Interest expense                                                                                                                                          36,706

Lease payments                                                                                                                                      (297,450)

Foreign exchange                                                                                                                                       (3,736)

 

Balance, December 31, 2021                                                                                                                     416,040

Addition (ii)                                                                                                                                               282,041

Interest expense                                                                                                                                          18,857

Lease payments                                                                                                                                      (701,782)

Foreign exchange                                                                                                                                      (15,156)

 

Balance, December 31, 2022                                                                                                            $        -         

 

(i) During the year ended 2021, the Company entered into lease agreements in respect to rent of equipments which expired between February 2022 to July 2022.

 

(ii) During the year ended December 31, 2022, the Company entered into lease agreements in respect to rent of equipments, all of which expired in July 2022.


16.     Share Capital and Reserves

 

a)       Authorized share capital

 

At December 31, 2022, the authorized share capital consisted of an unlimited number of common and preference shares issuable in Series.

 

The common shares do not have a par value. All issued shares are fully paid.

 

No preference shares have been issued. The preference shares do not have a par value.

 

b)         Common shares issued

 

At December 31, 2022, the issued share capital amounted to $69,664,056. The continuity of issued share capital for the years presented is as follows:

                                                                                                                                    Number of

                                                                                                                                     common

                                                                                                                                       shares            Amount

 

Balance, December 31, 2020                                                                                          46,565,537   $ 52,933,594   

Shares issued in private placement (i)                                                                              26,663,264          7,998,980     

Warrants issued (i)                                                                                                               -                (3,258,578)

Share issue costs                                                                                                                 41,667          (783,920)     

Exercise of warrants                                                                                                         1,413,333           893,494

 

Balance, December 31, 2021                                                                                           74,683,801       57,783,570   

Shares issued in private placement (ii)                                                                             13,111,119         5,900,003     

Shares issued for services arrangement (ii)                                                                        2,222,222          1,000,000     

Warrants issued (ii)                                                                                                              -                (1,644,859)

Share issue costs                                                                                                                -                   (752,324)

Exercise of warrants                                                                                                       13,501,367          7,377,666     

 

Balance, December 31, 2022                                                                                         103,518,509      $ 69,664,056   

 

 

(i) On May 14, 2021, Galantas completed a private placement of 26,663,264 units at a price of $0.30 per unit for aggregate gross proceeds of $7,998,980. Each unit comprises one common share and one common share purchase warrant. Each warrant will be exercisable into one additional common share at an exercise price of $0.40 for 24 months from the closing date of the private placement. There is a four‑month and one day hold period on the trading of securities issued in connection with this private placement.

 

The fair value of the 26,663,264 warrants was estimated at $3,258,578 using the Black‑Scholes option pricing model with the following assumptions: expected dividend yield ‑ 0%, expected volatility ‑ 155.08%, risk‑free interest rate ‑ 0.32% and an expected average life of 2 years.

 

Ocean Partners acquired 1,666,667 units of the private placement, for consideration of $500,000 and the Company paid a finder's fee of 41,667 units to Ocean Partners resulting in the issuance of 1,708,334 common shares or 2.3% of the Company's issued and outstanding common shares on a non‑diluted basis.

 

The 41,667 units paid as a finder's fee were valued at $20,417. The fair value of the 41,667 warrants was estimated at $8,783 using the Black‑Scholes option pricing model with the following assumptions: expected dividend yield ‑ 0%, expected volatility ‑ 155.08%, risk‑free interest rate ‑ 0.32% and an expected average life of 2 years.


 

Roland Phelps, the Company's retired President and Chief Executive Officer, acquired 166,667 units for consideration of $50,000, increasing his holding to 5,100,484 common shares or 6.9% of the Company's issued and outstanding common shares on a non‑diluted basis.

 

In respect of an under‑writing by Ocean Partners, the Company paid a commitment fee of $112,500 in cash.

 

(ii) On August 30, 2022, Galantas completed a private placement of 13,111,119 units at a price of $0.45 per unit for aggregate gross proceeds of $5,900,003.

 

In addition, 2,222,222 units were sold to a third‑party service provider on the same term as the offering. The gross proceeds being $1,000,000 was offset against certain fees to be paid to the third‑party service provider by the Company pursuant to a service agreement between the third‑party service provider and the Company dated August 30, 2022, for the underground development at the Omagh Gold Project commencing in January 2023.

 

Each unit comprises one common share and one‑half common share purchase warrant. Each warrant will be exercisable into one additional common share at an exercise price of $0.55 until February 28, 2025.

 

The fair value of the 7,666,669 warrants was estimated at $1,644,859 using the Black‑Scholes option pricing model with the following assumptions: expected dividend yield ‑ 0%, expected volatility ‑ 128.35%, risk‑free interest rate ‑ 3.64% and an expected average life of 2.5 years.

 

The Company paid the agents a cash commission equal to $355,320 and issue 820,000 non‑transferable broker warrants of the Company. Each broker warrant is exercisable to acquire one common share at an exercise price of $0.45 until August 30, 2024. The fair value of the 820,000 warrants was estimated at $144,464 using the Black‑Scholes option pricing model with the following assumptions: expected dividend yield ‑ 0%, expected volatility ‑ 109.13%, risk‑free interest rate ‑ 3.63% and an expected average life of 2 years.

 

Melquart Limited ("Melquart") acquired 2,666,667 units for consideration of $1,200,000. Following the offering, Melquart holds 28,140,195 common shares, representing approximately 27.36% of the issued and outstanding common shares on a non‑diluted basis. Ocean Partners acquired 461,112 units of the private placement, for consideration of $207,500. Mario Stifano, a director of the Company, acquired 55,556 units for consideration of $25,000.

 

c)      Warrant reserve

 

The following table shows the continuity of warrants for the years presented:

                                                                                                                                                           Weighted

                                                                                                                                                             average

                                                                                                                                    Number of        exercise

                                                                                                                                     warrants            price

 


Balance, December 31, 2020                                                                                           1,700,000         $ 0.33 

Issued (notes 14(i) and 16(b)(i))                                                                                       28,404,931        0.40 

Expired                                                                                                                          (1,413,333)                       0.35 

 

Balance, December 31, 2021                                                                                          28,691,598           0.39 

Issued (notes 16(b)(ii) and 20(a)(iii))                                                                                   8,861,669        0.54 

Exercised                                                                                                                     (13,501,367)                       0.39

 

Balance, December 31, 2022                                                                                          24,051,900       $ 0.45

 


 


The following table reflects the actual warrants issued and outstanding as of December 31, 2022:

 

                                                                                                                         Grant date                    Exercise

                                                                                     Number                        fair value                       price

Expiry date                                                                 of warrants                           ($)                               ($)

 

February 3, 2023                                                                250,000                         51,000                            0.50

May 14, 2023 (notes 20(a)(iii)(1))                                     14,410,231                     1,764,798                            0.40

July 25, 2023                                                                     125,000                         23,000                            0.48

December 31, 2023                                                            780,000                        274,883                            0.33

August 30, 2024                                                                 820,000                        212,000                            0.45

February 28, 2025                                                           7,666,669                     2,320,000                            0.55

 

                                                                                    24,051,900                     4,645,681                            0.45

 

 

d)       Stock options

 

The Company has a stock option plan (the "Plan"), the purpose of which is to attract, retain and compensate qualified persons as directors, senior officers and employees of, and consultants to the Company and its affiliates and subsidiaries by providing such persons with the opportunity, through share options, to acquire an increased proprietary interest in the Company. The number of shares reserved for issuance under the Plan cannot be more than a maximum of 10% of the issued and outstanding shares at the time of any grant of options. The period for exercising an option shall not extend beyond a period of five years following the date the option is granted.

 

Insiders of the Company are restricted on an individual basis from holding options which when exercised would entitle them to receive more than 5% of the total issued and outstanding shares at the time the option is granted. The exercise price of options granted in accordance with the Plan must not be lower than the closing price of the shares on the TSXV immediately preceding the date on which the option is granted and in no circumstances may it be less than the permissible discounting in accordance with the Corporate Finance Policies of the TSXV.

 

The Company records a charge to the consolidated statements of loss using the Black‑Scholes option pricing model. The valuation is dependent on a number of inputs and estimates, including the strike price, exercise price, risk‑free interest rate, the level of stock volatility, together with an estimate of the level of forfeiture. The level of stock volatility is calculated with reference to the historic traded daily closing share price at the date of issue.

 

Option pricing models require the inputs including the expected price volatility. Changes in the inputs can materially affect the fair value estimate.


 

The following table shows the continuity of stock options for the years presented:

                                                                                                                                                           Weighted

                                                                                                                                                             average

                                                                                                                                    Number of        exercise

                                                                                                                                      options             price

 

Balance, December 31, 2020                                                                                              570,000         $ 1.16 

Granted (i)(ii)(iii)                                                                                                                4,360,000         0.85 

Cancelled (v)                                                                                                                      (45,000)                       1.13 

 

Balance, December 31, 2021                                                                                            4,885,000         0.88 

Granted (iv)                                                                                                                      1,742,500                 0.60

Expired                                                                                                                            (255,000)                       1.35 

Cancelled (v)                                                                                                                    (220,000)                       0.94 

 

Balance, December 31, 2022                                                                                            6,152,500  $             0.78

 

(i) On May 19, 2021, the Company granted 3,915,000 stock options to directors, employees and consultants of the Company to purchase common shares at $0.86 per share until May 19, 2026. The options will vest as to one third immediately and one third on each of May 19, 2022 and May 19, 2023. The fair value attributed to these options was $2,907,000 and was expensed in the consolidated statements of loss and credited to equity settled share‑based payments reserve.

 

(ii) On June 21, 2021, the Company granted 425,000 stock options to consultants and officers of the Company to purchase common shares at $0.73 per share until June 21, 2026. The options will vest as to one third immediately and one third on each of June 21, 2022 and June 21, 2023. The fair value attributed to these options was $266,000 and was expensed in the consolidated statements of loss and credited to equity settled share‑based payments reserve.

 

(iii) On August 27, 2021, the Company granted 20,000 stock options to an employee of the Company to purchase common shares at $0.86 per share until August 27, 2026. The options will vest as to one third immediately and one third on each of August 27, 2022 and August 27, 2023. The fair value attributed to these options was $11,000 and was expensed in the consolidated statements of loss and credited to equity settled share‑based payments reserve.

 

(iv) On May 3, 2022, the Company granted 1,742,500 stock options to directors, officers, employees and consultants of the Company to purchase common shares at $0.60 per share until May 3, 2027. The options will vest as to one third immediately and one third on each of May 3, 2023 and May 3, 2024. The fair value attributed to these options was $900,000 and was expensed in the consolidated statements of loss and credited to equity settled share‑based payments reserve.

 

(v) The portion of the estimated fair value of options granted in the current and prior years and vested during the year ended December 31, 2022, amounted to $1,470,418 (year ended December 31, 2021 ‑ $2,035,878, respectively). In addition, during the year ended December 31, 2022, 200,000 options granted in the prior years were cancelled (year ended December 31, 2021 ‑ 45,000 options cancelled).


 

The following table reflects the actual stock options issued and outstanding as of December 31, 2022:

 

                                         Weighted average                                      Number of                   

                                                 remaining              Number of                options              Number of

                      Exercise             contractual               options                   vested                  options

Expiry date              price ($)              life (years)             outstanding           (exercisable)            unvested

 

April 19, 2023               1.10                      0.30                            25,000                    25,000                 -          

February 13, 2024        0.90                      1.12                            85,000                    85,000                 -          

June 27, 2024              0.90                      1.49                          100,000                  100,000                -           

May 19, 2026               0.86                      3.38                       3,760,000               2,506,667              1,253,333  

June 21, 2026              0.73                      3.47                          425,000                  283,333                 141,667  

August 27, 2026           0.86                      3.66                            20,000                    13,333                    6,667

May 3, 2023                 0.60                      4.34                       1,737,500                  579,167              1,158,333  

 

                       0.78                      3.59                       6,152,500                3,592,500              2,560,000  

 

 

17.     Net Loss per Common Share

 

The calculation of basic and diluted loss per share for the year ended December 31, 2022 was based on the loss attributable to common shareholders of $16,633,939 (year ended December 31, 2021 ‑ $5,284,431) and the weighted average number of common shares outstanding of 89,401,620 (year ended December 31, 2021 ‑ 64,122,021) for basic and diluted loss per share. Diluted loss did not include the effect of 24,051,900 warrants (year ended December 31, 2021 ‑ 28,691,598) and 6,152,500 options (year ended December 31, 2021 ‑ 4,885,000) for the year ended December 31, 2022, as they are anti‑dilutive.

 

18.     Revenues

 

Shipments of concentrate under the off‑take arrangements commenced during the second quarter of 2019. Concentrate sales provisional revenues during the year ended December 31, 2022 totalled approximately US$608,000 (CAD$823,475) (year ended December 31, 2021 ‑ US$1,114,000 (CAD$1,412,329)). However, until the mine reaches the commencement of commercial production, the net proceeds from concentrate sales will be offset against Development assets.


19.     Taxation

 

(a)      Provision for income taxes

 

The reported recovery of income taxes differs from amounts computed by applying the statutory income tax rates to the reported loss before income taxes due to the following:

 

Year Ended December 31,                                                                                                2022                2021

 


Loss before income taxes                                                                                          $ (16,633,939)        $ (5,284,431)   

 

Expected tax recovery at statutory rate of 26.5% (2021 ‑ 26.5%)                                       (4,407,994)   (1,400,374)   

Difference resulting from:

     Foreign tax rate differential                                                                                             191,802         29,556         

     Stock‑based compensation                                                                                            389,661          539,508       

     Share issue costs directly in equity                                                                               (128,866)          -      

     Permanent differences and other                                                                                  1,587,816         (645,388)     

     Change in deferred income tax assets not recognized                                                    2,367,581          1,476,698     

 

                                                                                                                                 $        -            $        -         

 

 

(b)      Deferred tax balances

 

The temporary differences and unused tax losses that give rise to deferred income tax balances are presented below:

 

As at December 31,                                                                                                           2022                2021

 


Deferred income tax assets (liabilities)                                                                       

     Losses carried forward                                                                                          $   14,600,831       $ 12,849,356   

     Share issue costs and other                                                                                           270,340      221,875       

     Non‑current assets                                                                                                     (3,130,509)        (3,698,150)   

     Deferred tax assets not recognized                                                                           (11,740,662)     (9,373,081)   

 

                                                                                                                                 $        -            $        -         

 


 

(c)      Losses carried forward

 

As at December 31, 2022, the Company had non‑capital losses carried forward, available to offset future taxable income for income tax purposes as follows:

 

Expires                                  2026                                              $ 1,064,484    

                                  2027                                                598,595

                                  2029                                                373,962

                                  2030                                                440,512

                                  2031                                                993,770

                                  2032                                                600,689

                                  2033                                             1,100,268       

                                  2034                                                906,488

                                  2035                                                884,526

                                  2036                                                901,063

                                  2037                                                772,787

                                  2038                                                891,330

                                  2039                                             1,027,232

                                  2040                                             1,321,064

                                  2041                                             1,409,184

                                  2042                                             2,173,300

Indefinite                                                                       43,389,979

                                                                               $   58,849,233

 

At December 31, 2022, the potential benefit of these losses and deductible temporary differences in excess of the deferred tax liabilities have not been recognized in these consolidated financial statements as it is not considered probable that sufficient future tax profit will allow the deferred tax assets to be recovered.

 

20.     Related Party Disclosures

 

Related parties pursuant to IFRS include the Board of Directors, close family members, other key management individuals and enterprises that are controlled by these individuals as well as certain persons performing similar functions.

 

Related party transactions conducted in the normal course of operations are measured at the exchange amount and approved by the Board of Directors in strict adherence to conflict of interest laws and regulations.

 

(a) The Company entered into the following transactions with related parties:

 

                                                                                                                                                 Year Ended

                                                                                                                                               December 31,

                                                                                                                                           2022               2021

 

     Interest on related party loans                     (i)                                                           $        554,073       $ 340,092     

 

 

(i) Refer to note 20(a)(iii).

 

(ii) Refer to note 16(b).


 

(iii) As at December 31, 2021, Ocean Partners and the Company have a common director. As a result, the balance due to the Lender was reallocated from financing facilities to due to related parties. Total balance reallocated consisted of $2,577,137. Refer to note 14(i).

 

On May 14, 2021, the maturity date of the loan facility due on December 31, 2021 has been extended to December 31, 2023. Interest may be deferred and added to the balance outstanding until March 31, 2022, at which point interest will be paid monthly. During the year ended December 2021, the 1,700,000 Bonus Warrants issued have been extended.

 

The Company recorded the incremental difference of $251,000 as financing costs based on the fair value of these warrants immediately prior to and after the modification. The fair value of the 1,700,000 Bonus Warrants was valued immediately prior to the subsequent extension using the following Black‑Scholes option pricing model with the following assumptions: expected dividend yield ‑ 0%, expected volatility ‑ 123.98% to 144.48%, risk‑free interest rate ‑ 0.32% and an expected average life of 0.63 to 2.63 years.

 

On February 3, 2022, the Company announced the closing of the loan agreement for US$1.06 million with Ocean Partners. Ocean Partners and the Company have a common director. Terms of the loan agreement are:

 

·      The loan matured on July 31, 2022.

·      The loan will bear interest at an annual rate of 10% compounded monthly payable upon repayment of the loan.

·      US$20,000 structuring fee has been paid to Ocean Partners.

·      US$40,000 consulting fee will be paid to Ocean Partners.

·      250,000 warrants have been granted to Ocean Partners, which will be exercisable for a period of 12 months at an exercise price of $0.50. The bonus warrants are subject to a hold period under applicable securities laws and the rules of  the TSXV, expiring on June 4, 2022. The fair value of the 250,000 warrants was valued at $51,000 using the following Black‑Scholes option pricing model with the following assumptions: expected dividend yield ‑ 0%, expected volatility ‑ 107%, risk‑free interest rate ‑ 1.22% and an expected average life of 1 year.

·      US$40,000 extension fee was paid to Ocean Partners if the Company elects to extend the loan for a further six months from the maturity date. The Company exercised its option to extend the US$1.06 million loan for a further six months, to January 31, 2023 by paying the US$40,000 extension fee to Ocean Partners.

 

Proceeds from the loan will be used for further development of the Omagh mine in Northern Ireland and working capital.

 

On August 3, 2022, the Company announced the closing of the loan agreement for US$530,000 with Ocean Partners. Terms of the loan agreement are:

 

·      The loan matures on January 31, 2023.

·      The loan will bear interest at an annual rate of 12% compounded monthly and repayable in full on the maturity date.

·      US$10,000 commitment fee has been paid to Ocean Partners.

·      125,000 bonus warrants have been granted to Ocean Partners, which will be exercisable for a period of 12 months at an exercise price of $0.48. The bonus warrants are subject to a hold period under applicable securities laws and the rules of the TSXV, expiring on July 25, 2023. The fair value of the 125,000 warrants was valued at $23,000 using the following Black‑Scholes option pricing model with the following assumptions: expected dividend yield ‑ 0%, expected volatility ‑ 95.09%, risk‑free interest rate ‑ 3.12% and an expected average life of 1 year.


 

·      US$20,000 extension fee will be paid to Ocean Partners if the Company elects to extend the loan for a further six months from the maturity date.

 

As at December 31, 2022, financial liabilities due to the lender and recorded as due to related parties on the consolidated statement of financial position is $4,978,069 (December 31, 2021 ‑ $2,444,376).

 

                                                                                                                                   December 31,  December 31,

                                                                                                                                          2022                2021

 

Balance, beginning of year                                                                                           $     2,444,376            $          -   

Financing facility reallocated to due to related parties                                                              -                  2,577,137

Loan received                                                                                                                     2,062,693                       -   

Less bonus warrants                                                                                                              (74,000)          (251,000)

Share issue costs                                                                                                                  (93,444)             -         

Advance                                                                                                                                 93,284             -         

Repayment                                                                                                                          (524,255)             -         

Accretion                                                                                                                              391,128             57,338

Interest                                                                                                                                  554,073             27,506

Foreign exchange adjustment                                                                                                 124,214             33,395

 

Balance, end of year                                                                                                           4,978,069         2,444,376

Less current balance                                                                                                         (4,978,069)             -         

 

Due to related parties ‑ non‑current balance                                                                   $        -            $     2,444,376

 

 

Trading agreement

 

In December 2022, the Company entered into an agreement (the "Trading Agreement") with Ocean Partners, whereby Ocean Partners has sold on behalf of Galantas call options on 6,000 ounces of gold at 500 ounces per month from February 2024 to January 2025 at a strike price of US$1,775 per ounce for proceeds of US$804,000 to Galantas (an option premium of US$134 per gold ounce). Proceeds from the sale will be used to fund development of the underground mining operations at the Omagh Gold Project in Northern Ireland and working capital.

 

If the gold price during February 2024 to January 2025 is at or below US$1,775 per ounce, Galantas will receive the price of gold at the time for the sale of its gold produced. If the gold price is above US$1,775 per ounce, Galantas will receive US$1,775 per ounce in revenue for the sale of its gold.


 

Pursuant to the Trading Agreement, and in return for Ocean Partners facilitating the call option sale and agreeing to maintain all margin requirements on Galantas' behalf, which Galantas has determined has a value of at least $150,000, Galantas has agreed to grant 500,000 warrants to Ocean Partners at an exercise price of $0.55 expiring on January 31, 2025. The warrants are subject to a hold period under applicable securities laws and the rules of the TSXV.

 

The Trading Agreement and the issuance of warrants to Ocean Partners shall be subject to the approval of the TSXV. There is no assurance that TSXV approval will be obtained.

 

No finder's fees will be paid in connection with the Trading Agreement.

 

As at December 31, 2022, balance related to the Trading Agreement is recorded as other liability on the consolidated statement of financial position is $1,085,426 (December 31, 2021 ‑ $nil).

 

(b) Remuneration of officer and directors of the Company was as follows:

 

                                                                                                                                                Year Ended

                                                                                                                                               December 31,

                                                                                                                                           2022               2021

Salaries and benefits (1)                                                                                                $        558,941         $ 382,570     

Stock‑based compensation                                                                                                   930,223         1,365,577

 

                                                                                                                                   $     1,489,164   $     1,748,147

                                            

 

(1) Salaries and benefits include director fees. As at December 31, 2022, due to directors for fees amounted to $70,000 (December 31, 2021 ‑ $102,917) and due to officers, mainly for salaries and benefits accrued amounted to $24,465 (December 31, 2021 ‑ $21,400), and is included with due to related parties.

 

(c) As at December 31, 2022, Ross Beaty owns 3,744,748 common shares of the Company or approximately 3.6% of the outstanding common shares. Premier Miton owns 4,848,243 common shares of the Company or approximately 4.7%. Melquart owns, directly and indirectly, 28,140,195 common shares of the Company or approximately 27.2% of the outstanding common shares of the Company. G&F Phelps owns 5,353,818 common shares of the Company or approximately 5.2%. Eric Sprott owns 10,166,667 common shares of the Company or approximately 9.8%. Mike Gentile owns 6,217,222 common shares of the Company or approximately 6.0%. The remaining 43.5% of the shares are widely held, which includes various small holdings which are owned by directors of the Company. These holdings can change at anytime at the discretion of the owner.

 

The Company is not aware of any arrangements that may at a subsequent date result in a change in control of the Company.


 

(d) Additional disclosures required for Alternate Investment Market ("AIM") reporting:

 

Pursuant to the AIM Rules for Companies (the "AIM Rules"), a related party is any person who is; a director of an AIM company, a substantial shareholder (any person who has a shareholding greater than 10%), their associates, or any person who was a director of an AIM company or a substantial shareholder within the twelve months preceding the date of the transaction.

 

     1. As described in note 14, Roland Phelps i and Melquart ii participated in the private placement in May 2021.

     2. As described in note 14, the maturity date of the G&F Phelps i loan was extended to December 31, 2023.

     3. Related party balances  Loan accounts - owed to related parties

 

                                                                                                                                               December 31,

                                                                                                                                           2022               2021

 

     G&F Phelps                                               (i)                                                           $         -          $     4,247,488

     Ocean Partners                                        (iii)                                                                 4,978,069       2,444,376  

 

     Total                                                                                                                       $     4,978,069                     $ 6,691,864  

 

 

(i) G&F Phelps is deemed to be a related party of the Company by virtue of being controlled by Roland Phelps who has been a Director of the Company in the last twelve months.

(ii) Pursuant to the AIM Rules, Melquart is deemed to be a related party of the Company by virtue of being a substantial shareholder in the Company.

(iii) Pursuant to IFRS, Ocean Partners are deemed to be a related of the Company as they have a common director.

 

                                                                                                                                                Year Ended

                                                                                                                                               December 31,

Salaries and benefits                                                                                                           2022               2021

Roland Phelps, former CEO                                                                                          $        -            $         86,230

Mario Stifano, CEO                                                                                                               246,894            107,406

Alan Buckley, CFO                                                                                                                172,047             91,767

Brent Omland, director                                                                                                             30,000             17,500

David Cather, director                                                                                                              30,000             20,500

James B. Clancy, director                                                                                                        30,000             21,000

James L. Golla, director                                                                                                          -                        3,000

Ronald Alexander, director                                                                                                      -                        2,750

Roisin Magee, director                                                                                                             50,000             32,417

 

                                                                                                                                   $       558,941   $       382,570

                                            


 

The Company awarded incentive stock options on the Company's common shares to directors and officers in accordance with the terms of the Company's incentive Stock Option Plan as set out in the below table. The table also shows the fair value of stock received during the year using the Black‑Scholes option pricing model.

 

                                                                                            Number of options           Share‑based compensation

                                                                                                  Year Ended                            Year Ended

                                                                                                December 31,                         December 31,

                                                                   Notes                 2022                2021                 2022               2021

Roland Phelps, former CEO                          16(d)                    -                       -             $        -            $              304

Mario Stifano, CEO                                      16(d)                   500,000          1,500,000            498,713       716,083

Alan Buckley, CFO                                       16(d)                   125,000             250,000              97,427      119,347

Brendan Morris, COO                                   16(d)                   125,000             100,000              63,186      37,410

Brent Omland, director                                  16(d)                     62,500             375,000              81,754       179,021

David Cather, director                                   16(d)                     62,500             125,000              48,713     60,614

James B. Clancy, director                             16(d)                     62,500             125,000              48,713      59,825

James L. Golla, director                                16(d)                    -                      125,000             -                      59,825

Ronald Alexander, director                            16(d)                    -                       -                       -                           152

Roisin Magee, director                                  16(d)                     92,500             275,000              91,717     132,996

 

                                                                                          1,030,000          2,875,000   $       930,223   $     1,365,577

                                            

 

21.     Segment Disclosure

 

The Company has determined that it has one reportable segment. The Company's operations are substantially all related to its investment in Cavanacaw and its subsidiaries, Omagh and Flintridge. Substantially all of the Company's revenues, costs and assets of the business that support these operations are derived or located in Northern Ireland. Segmented information on a geographic basis is as follows:

 

December 31, 2022                                                                             United Kingdom     Canada              Total

 

Current assets                                                                                       $    1,659,045   $     1,273,833  $    2,932,878

Non‑current assets                                                                                $   27,271,081   $       139,741  $   27,410,822

Revenues                                                                                             $        -             $        -            $        -         

                                            

 

December 31, 2021                                                                             United Kingdom     Canada              Total

 

Current assets                                                                                       $    1,379,742   $     1,078,732  $    2,458,474

Non‑current assets                                                                                $   27,714,667   $         62,312  $   27,776,979

Revenues                                                                                             $        -             $        -            $        -         

                                            


22.     Contingency

 

During the year ended December 31, 2010, the Company's subsidiary Omagh received a payment demand from Her Majesty's Revenue and Customs ("HMRC") in the amount of $496,662 (GBP 304,290) in connection with an aggregate levy arising from the removal of waste rock from the mine site during 2008 and early 2009. Omagh believed this claim to be without merit. An appeal was lodged with the Tax Tribunals Service and the hearing started at the beginning of March 2017 and following a number of adjournments was completed in August 2018. During the year ended December 31, 2019, the Tax Tribunals Service issued their judgement dismissing the appeal by Omagh in respect of the assessments. A provision has now been included in the consolidated financial statements in respect of the aggregates levy plus interest and penalty.

 

There is a contingent liability in respect of potential additional interest which may be applied in respect of the aggregates levy dispute. Omagh is unable to make a reliable estimate of the amount of the potential additional interest that may be applied by HMRC.

 

23.     Events After the Reporting Period

 

(i) On January 26, 2023, the Company announced that it entered into an agreement to acquire a 100% interest and the exclusive rights to explore and develop the Gairloch Project from the owners of the Gairloch Estate lands. The Company has acquired exploration and developments rights for an initial payment of GBP 347,000 and annual payments of GBP 69,000 beginning in year 6.

 

The lease agreement will continue for 30 years and will be renewable at the election of Galantas, upon 90 days' prior written notice and upon the approval of the lessor, not to be unreasonably withheld, for a further 20‑year period, assuming all conditions of this agreement have been met satisfactorily according to the Lessor, acting reasonably, in respect of the Galantas' conduct and operations. Galantas may terminate the agreement with 18 months' notice.

 

Galantas will make a payment of GBP 347,000 representing payment for the first five years of the lease. If the exploration phase continues past the fifth anniversary of the effective date of the agreement, Galantas will pay the lessor GBP 69,400 index linked per lease year for each such lease year following the fifth anniversary of the effective date, with such payment to be made at the commencement of each such lease year.

 

During any mining phase, Galantas will pay the lessor GBP 50,000 index linked per lease year, with such payment to be made at the commencement of each such lease year. Galantas will grant a 5% net profits interest royalty (the "NPI"), calculated according to standard industry terms and practices with the option by the Lessor to convert the NPI to a 2% net smelter returns royalty, calculated according to standard industry terms and practices.

 

The Company has separately entered into an agreement to acquire the historical drill and exploration database for (i) a payment of $420,000 (approximately GBP 252,153), to be satisfied through the issuance of common shares of the Company based on the 5‑day volume weighted average price at the time of signing (subject to the approval of the TSXV) and (ii) GBP 50,000 in cash.


 

(ii) On February 13, 2023, the Company announced that it entered into a loan agreement for GBP 347,000 with London‑based family office Melquart. The loan is to be used for the initial lease payment for the Gairloch Project in Scotland. The loan is payable 24 months from the date of the loan agreement and will bear interest at an annual rate of 12% payable upon repayment of the loan.

 

As consideration for providing the loan, Melquart will receive upon closing of the loan agreement, 100,000 warrants of Galantas, subject to acceptance by the TSXV. Each bonus warrant will be exercisable into one common share of Galantas for a period of 24 months from the closing at an exercise price equal to the closing price of the Company's common shares on the TSXV on February 10, 2023.

 

The above terms are subject to TSXV approval under the TSXV Policy 5.1 ‑ Loans, Loan Bonuses, Finder's Fees and Commissions.

 

(iii) On March 27, 2023, the Company announced that it closed a non‑brokered private placement of 8,230,951 units at a price of $0.36 per unit for gross proceeds of $2,963,142. Each unit consists of one common share of the Company and one common share purchase warrant, with each warrant entitling the holder to purchase an additional common share at a price of $0.55 per share until March 27, 2028. There is a 4‑month hold period on the trading of securities issued in connection with this offering.

 

The Company paid the agents a cash commission equal to $130,966 and issued 237,162 non‑transferable broker warrants of the Company. Each broker warrant is exercisable to acquire one common share at an exercise price of $0.36 until March 27, 2025.

 

In addition, the Company announced it agreed to the terms of a proposed shares‑for‑debt transaction with several additional arm's length creditors of the Company. In connection with the debt settlement, the Company agreed to settle a total of approximately $749,020 of indebtedness through the issuance of an aggregate of 2,080,609 units a deemed price of $0.36 per unit on substantially in the same terms as the units issued under the offering. The securities pursuant to the debt settlement will be subject to a four‑month hold period under applicable Canadian securities laws.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FR UWRBROWUSUAR
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. AJ Bell logo

Related Charts

Galantas Gold Corporation (GAL)

-0.25p (-6.25%)
delayed 13:30PM